{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import os\n",
    "from glob import glob\n",
    "import matplotlib.pyplot as plt\n",
    "pd.set_option('display.max_colwidth', None)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['ICUSTAYS.csv.gz',\n",
       " 'MICROBIOLOGYEVENTS.csv.gz',\n",
       " 'PROCEDUREEVENTS_MV.csv.gz',\n",
       " 'PRESCRIPTIONS.csv.gz',\n",
       " 'DRGCODES.csv.gz',\n",
       " 'D_LABITEMS.csv.gz',\n",
       " 'D_ICD_DIAGNOSES.csv.gz',\n",
       " 'PATIENTS.csv.gz',\n",
       " 'CALLOUT.csv.gz',\n",
       " 'PROCEDURES_ICD.csv.gz',\n",
       " 'DATETIMEEVENTS.csv.gz',\n",
       " 'D_ICD_PROCEDURES.csv.gz',\n",
       " 'NOTEEVENTS.csv.gz',\n",
       " 'D_CPT.csv.gz',\n",
       " 'D_ITEMS.csv.gz',\n",
       " 'SERVICES.csv.gz',\n",
       " 'CHARTEVENTS.csv.gz',\n",
       " 'LABEVENTS.csv.gz',\n",
       " 'DIAGNOSES_ICD.csv.gz',\n",
       " 'ADMISSIONS.csv.gz',\n",
       " 'CAREGIVERS.csv.gz',\n",
       " 'TRANSFERS.csv.gz',\n",
       " 'CPTEVENTS.csv.gz',\n",
       " 'INPUTEVENTS_MV.csv.gz',\n",
       " 'OUTPUTEVENTS.csv.gz',\n",
       " 'INPUTEVENTS_CV.csv.gz']"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mimic_notes_tables = [os.path.basename(i) for i in glob(\"../*.csv.gz\")]\n",
    "mimic_notes_tables"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "patients = pd.read_csv(\"../PATIENTS.csv.gz\", compression=\"gzip\", low_memory=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ROW_ID</th>\n",
       "      <th>SUBJECT_ID</th>\n",
       "      <th>GENDER</th>\n",
       "      <th>DOB</th>\n",
       "      <th>DOD</th>\n",
       "      <th>DOD_HOSP</th>\n",
       "      <th>DOD_SSN</th>\n",
       "      <th>EXPIRE_FLAG</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>234</td>\n",
       "      <td>249</td>\n",
       "      <td>F</td>\n",
       "      <td>2075-03-13 00:00:00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>235</td>\n",
       "      <td>250</td>\n",
       "      <td>F</td>\n",
       "      <td>2164-12-27 00:00:00</td>\n",
       "      <td>2188-11-22 00:00:00</td>\n",
       "      <td>2188-11-22 00:00:00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>236</td>\n",
       "      <td>251</td>\n",
       "      <td>M</td>\n",
       "      <td>2090-03-15 00:00:00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>237</td>\n",
       "      <td>252</td>\n",
       "      <td>M</td>\n",
       "      <td>2078-03-06 00:00:00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>238</td>\n",
       "      <td>253</td>\n",
       "      <td>F</td>\n",
       "      <td>2089-11-26 00:00:00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   ROW_ID  SUBJECT_ID GENDER                  DOB                  DOD  \\\n",
       "0     234         249      F  2075-03-13 00:00:00                  NaN   \n",
       "1     235         250      F  2164-12-27 00:00:00  2188-11-22 00:00:00   \n",
       "2     236         251      M  2090-03-15 00:00:00                  NaN   \n",
       "3     237         252      M  2078-03-06 00:00:00                  NaN   \n",
       "4     238         253      F  2089-11-26 00:00:00                  NaN   \n",
       "\n",
       "              DOD_HOSP DOD_SSN  EXPIRE_FLAG  \n",
       "0                  NaN     NaN            0  \n",
       "1  2188-11-22 00:00:00     NaN            1  \n",
       "2                  NaN     NaN            0  \n",
       "3                  NaN     NaN            0  \n",
       "4                  NaN     NaN            0  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "patients.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(46520, 8)"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "patients.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "notes = pd.read_csv(\"../NOTEEVENTS.csv.gz\", compression=\"gzip\", low_memory=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ROW_ID</th>\n",
       "      <th>SUBJECT_ID</th>\n",
       "      <th>HADM_ID</th>\n",
       "      <th>CHARTDATE</th>\n",
       "      <th>CHARTTIME</th>\n",
       "      <th>STORETIME</th>\n",
       "      <th>CATEGORY</th>\n",
       "      <th>DESCRIPTION</th>\n",
       "      <th>CGID</th>\n",
       "      <th>ISERROR</th>\n",
       "      <th>TEXT</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>174</td>\n",
       "      <td>22532</td>\n",
       "      <td>167853.0</td>\n",
       "      <td>2151-08-04</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Discharge summary</td>\n",
       "      <td>Report</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Admission Date:  [**2151-7-16**]       Discharge Date:  [**2151-8-4**]\\n\\n\\nService:\\nADDENDUM:\\n\\nRADIOLOGIC STUDIES:  Radiologic studies also included a chest\\nCT, which confirmed cavitary lesions in the left lung apex\\nconsistent with infectious process/tuberculosis.  This also\\nmoderate-sized left pleural effusion.\\n\\nHEAD CT:  Head CT showed no intracranial hemorrhage or mass\\neffect, but old infarction consistent with past medical\\nhistory.\\n\\nABDOMINAL CT:  Abdominal CT showed lesions of\\nT10 and sacrum most likely secondary to osteoporosis. These can\\nbe followed by repeat imaging as an outpatient.\\n\\n\\n\\n                            [**First Name8 (NamePattern2) **] [**First Name4 (NamePattern1) 1775**] [**Last Name (NamePattern1) **], M.D.  [**MD Number(1) 1776**]\\n\\nDictated By:[**Hospital 1807**]\\nMEDQUIST36\\n\\nD:  [**2151-8-5**]  12:11\\nT:  [**2151-8-5**]  12:21\\nJOB#:  [**Job Number 1808**]\\n</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>175</td>\n",
       "      <td>13702</td>\n",
       "      <td>107527.0</td>\n",
       "      <td>2118-06-14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Discharge summary</td>\n",
       "      <td>Report</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Admission Date:  [**2118-6-2**]       Discharge Date:  [**2118-6-14**]\\n\\nDate of Birth:                    Sex:  F\\n\\nService:  MICU and then to [**Doctor Last Name **] Medicine\\n\\nHISTORY OF PRESENT ILLNESS:  This is an 81-year-old female\\nwith a history of emphysema (not on home O2), who presents\\nwith three days of shortness of breath thought by her primary\\ncare doctor to be a COPD flare.  Two days prior to admission,\\nshe was started on a prednisone taper and one day prior to\\nadmission she required oxygen at home in order to maintain\\noxygen saturation greater than 90%.  She has also been on\\nlevofloxacin and nebulizers, and was not getting better, and\\npresented to the [**Hospital1 18**] Emergency Room.\\n\\nIn the [**Hospital3 **] Emergency Room, her oxygen saturation was\\n100% on CPAP.  She was not able to be weaned off of this\\ndespite nebulizer treatment and Solu-Medrol 125 mg IV x2.\\n\\nReview of systems is negative for the following:  Fevers,\\nchills, nausea, vomiting, night sweats, change in weight,\\ngastrointestinal complaints, neurologic changes, rashes,\\npalpitations, orthopnea.  Is positive for the following:\\nChest pressure occasionally with shortness of breath with\\nexertion, some shortness of breath that is positionally\\nrelated, but is improved with nebulizer treatment.\\n\\nPAST MEDICAL HISTORY:\\n1. COPD.  Last pulmonary function tests in [**2117-11-3**]\\ndemonstrated a FVC of 52% of predicted, a FEV1 of 54% of\\npredicted, a MMF of 23% of predicted, and a FEV1:FVC ratio of\\n67% of predicted, that does not improve with bronchodilator\\ntreatment.  The FVC, however, does significantly improve with\\nbronchodilator treatment consistent with her known reversible\\nair flow obstruction in addition to an underlying restrictive\\nventilatory defect.  The patient has never been on home\\noxygen prior to this recent episode.  She has never been on\\nsteroid taper or been intubated in the past.\\n2. Lacunar CVA.  MRI of the head in [**2114-11-4**]\\ndemonstrates \"mild degree of multiple small foci of high T2\\nsignal within the white matter of both cerebral hemispheres\\nas well as the pons, in the latter region predominantly to\\nthe right of midline.  The abnormalities, while nonspecific\\nin etiology, are most likely secondary to chronic\\nmicrovascular infarction.  There is no mass, lesion, shift of\\nthe normal midline strictures or hydrocephalus.  The major\\nvascular flow patterns are preserved.  There is moderate\\nright maxillary, moderate bilateral ethmoid, mild left\\nmaxillary, minimal right sphenoid, and frontal sinus mucosal\\nthickening.  These abnormalities could represent an allergic\\nor some other type of inflammatory process.  Additionally\\nnoted is a moderately enlarged subtotally empty sella\\nturcica\".\\n3. Angina:  Most recent stress test was in [**2118-1-3**]\\ngoing for four minutes with a rate pressure product of\\n10,000, 64% of maximum predicted heart rate without evidence\\nof ischemic EKG changes or symptoms.  The imaging portion of\\nthe study demonstrated no evidence of myocardial ischemia and\\na calculated ejection fraction of 84%.  The patient denies\\nangina at rest and gets angina with walking a few blocks.\\nAre alleviated by sublingual nitroglycerin.\\n4. Hypothyroidism on Synthroid.\\n5. Depression on Lexapro.\\n6. Motor vehicle accident with head injury approximately 10\\nyears ago.\\n\\nMEDICATIONS ON ADMISSION:\\n1. Hydrochlorothiazide 25 q.d.\\n2. Prednisone 60 mg, 50 mg, 40 mg, 20 mg.\\n3. Levofloxacin 500 mg q.d.\\n4. Imdur 60 mg q.d.\\n5. Synthroid 75 mcg q.d.\\n6. Pulmicort nebulizer b.i.d.\\n7. Albuterol nebulizer q.4. prn.\\n8. Lexapro 10 mg q.d.\\n9. Protonix 40 mg q.d.\\n10. Aspirin 81 mg q.d.\\n\\nALLERGIES:  Norvasc leads to lightheadedness and headache.\\n\\nFAMILY HISTORY:  Noncontributory.\\n\\nSOCIAL HISTORY:  Lives with her husband, Dr. [**Known lastname 1809**] an\\neminent Pediatric Neurologist at [**Hospital3 1810**].  The\\npatient is a prior smoker, but has not smoked in over 10\\nyears.  She has no known alcohol use and she is a full code.\\n\\nPHYSICAL EXAM AT TIME OF ADMISSION:  Blood pressure 142/76,\\nheart rate 100 and regular, respirations at 17-21, and 97%\\naxillary temperature.  She was saturating at 100% on CPAP\\nwith dry mucous membranes.  An elderly female in no apparent\\ndistress.  Pupils are equal, round, and reactive to light and\\naccommodation.  Extraocular movements are intact.  Oropharynx\\ndifficult to assess due to CPAP machine.  No evidence of\\njugular venous pressure, however, the strap from the CPAP\\nmachine obscures the neck exam.  Cranial nerves II through\\nXII are grossly intact.  Neck is supple without\\nlymphadenopathy.  Heart exam:  Tachycardic, regular, obscured\\nby loud bilateral wheezing with increase in the expiratory\\nphase as well as profuse scattered rhonchi throughout the\\nlung fields.  Positive bowel sounds, soft, nontender,\\nnondistended, obese, no masses.  Mild edema of the lower\\nextremities without clubbing or cyanosis, no rashes.  There\\nis a right hand hematoma.  Strength is assessed as [**5-9**] in the\\nlower extremities, [**5-9**] in the upper extremities with a normal\\nmental status and cognition.\\n\\nLABORATORY STUDIES:  White count 19, hematocrit 41, platelets\\n300.  Chem-7:  127, 3.6, 88, 29, 17, 0.6, 143.  Troponin was\\nnegative.  CKs were negative times three.  Initial blood gas\\nshowed a pH of 7.4, pO2 of 66, pCO2 of 54.\\n\\nChest x-ray demonstrates a moderate sized hiatal hernia,\\nsegmental atelectasis, left lower lobe infiltrate versus\\nsegmental atelectasis.\\n\\nEKG shows normal sinus rhythm at 113 beats per minute, normal\\naxis, no evidence of ST-T wave changes.\\n\\nBRIEF SUMMARY OF HOSPITAL COURSE:\\n1. COPD/dyspnea/pneumonia:  The patient was initially placed\\non an aggressive steroid taper and admitted to the Medical\\nIntensive Care Unit due to her difficulty with oxygenation\\ndespite CPAP machine.  She was also given nebulizer\\ntreatments q.4h. as well as chest PT.  The nebulizers were\\nincreased to q.1h. due to the fact that she continued to have\\nlabored breathing.\\n\\nDue to persistent respiratory failure and labored breathing,\\nthe patient was intubated on [**2118-6-7**] in order to improve\\noxygenation, ventilation, and ability to suction.  A\\nbronchoscopy was performed on [**2118-6-7**], which demonstrated\\nmarked narrowing of the airways with expiration consistent\\nwith tracheomalacia.\\n\\nOn [**2118-6-9**], two silicone stents were placed, one in the left\\nmain stem (12 x 25 and one in the trachea 16 x 40) by Dr.\\n[**First Name (STitle) **] [**Name (STitle) **] under rigid bronchoscopy with general anesthesia.\\n\\nOn [**2118-6-11**], the patient was extubated to a cool mist shovel\\nmask and her oxygen was titrated down to 2 liters nasal\\ncannula at which time she was transferred to the medical\\nfloor.  On the medical floor, the steroids were weaned to off\\non [**2118-6-14**], and the patient was saturating at 97% on 2\\nliters, 92% on room air.\\n\\nOn [**2118-6-14**], the patient was seen again by the Interventional\\nPulmonology service, who agreed that she looked much improved\\nand recommended that she go to pulmonary rehabilitation with\\nfollowup within six weeks' time status post placement of\\nstents in respiratory failure.\\n\\n2. Cardiovascular:  The patient was ruled out for a MI.  She\\ndid have another episode on the medical floor of chest pain,\\nwhich showed no evidence of EKG changes and negative\\ntroponin, negative CKs x3.  She was continued on aspirin,\\nImdur, and diltiazem for rate control per her outpatient\\nregimen.\\n\\n3. Hypertension:  She was maintained on diltiazem and\\nhydrochlorothiazide with adequate blood pressure control and\\nnormalization of electrolytes.\\n\\n4. Hematuria:  The patient had intermittent hematuria likely\\nsecondary to Foley placement.  The Foley catheter was\\ndiscontinued on [**2118-6-14**].  She had serial urinalyses, which\\nwere all negative for signs of infection.\\n\\n5. Hyperglycemia:  Patient was placed on insulin-sliding\\nscale due to hyperglycemia, which was steroid induced.  This\\nworked quite well and her glucose came back to normal levels\\nonce the steroids were tapered to off.\\n\\n6. Leukocytosis:  Patient did have a profound leukocytosis of\\n20 to 22 during much of her hospital course.  As the steroids\\nwere tapered to off, her white blood cell count on [**2118-6-14**]\\nwas 15,000.  It was felt that the leukocytosis was secondary\\nto both steroids as well as question of a left lower lobe\\npneumonia.\\n\\n7. For the left lower lobe pneumonia, the patient had\\ninitially received a course of levofloxacin 500 p.o. q.d.\\nfrom [**2118-6-4**] to [**2118-6-10**].  This was restarted on [**2118-6-12**]\\nfor an additional seven day course given the fact that she\\nstill had the leukocytosis and still had marked rales at the\\nleft lower lobe.\\n\\n8. Hypothyroidism:  The patient was continued on outpatient\\nmedical regimen.\\n\\n9. Depression:  The patient was continued on Lexapro per\\noutpatient regimen.  It is recommended that she follow up\\nwith a therapist as an outpatient due to the fact that she\\ndid have a blunted affect throughout much of the hospital\\ncourse, and did appear clinically to be depressed.\\n\\n10. Prophylaxis:  She was maintained on proton-pump inhibitor\\nwith subQ Heparin.\\n\\n11. Sore throat:  The patient did have a sore throat for much\\nof the hospital course post extubation.  This was treated\\nwith Cepacol lozenges as well as KBL liquid (a solution\\ncontaining Kaopectate, Bismuth, and lidocaine) at bedtime.\\n\\n12. Communication/code status:  The patient was full code\\nthroughout her hospital course, and communication was\\nmaintained with the patient and her husband.\\n\\n13. Muscle weakness:  The patient did have profound muscle\\nweakness and was evaluated by Physical Therapy, and was found\\nto have impaired functional mobility, impaired\\nmusculoskeletal performance, impaired gas exchange, impaired\\nendurance, impaired ventilation, and needed help with supine\\nto sit.  However, she was able to tolerate sitting in a chair\\nfor approximately one hour.\\n\\nOn motor exam, her flexors and extensors of the lower\\nextremities were [**4-8**] at the knee, [**4-8**] at the ankle, [**4-8**] at\\nthe elbows, and [**4-8**] hips.  It was felt that this weakness was\\nmost likely due to a combination of steroid myopathy as well\\nas muscle atrophy secondary to deconditioning after a\\nprolonged hospital course.\\n\\n14. Speech/swallow:  The patient had a Speech and Swallow\\nevaluation showing no evidence of dysphagia, no evidence of\\nvocal cord damage status post tracheal stent placement.\\n\\nDISCHARGE CONDITION:  The patient was able to oxygenate on\\nroom air at 93% at the time of discharge.  She was profoundly\\nweak, but was no longer tachycardic and had a normal blood\\npressure.  Her respirations were much improved albeit with\\ntransmitted upper airway sounds.\\n\\nDISCHARGE STATUS:  The patient will be discharged to [**Hospital1 **]\\nfor both pulmonary and physical rehabilitation.\\n\\nDISCHARGE MEDICATIONS:\\n1. Levothyroxine 75 mcg p.o. q.d.\\n2. Citalopram 10 mg p.o. q.d.\\n3. Aspirin 81 mg p.o. q.d.\\n4. Fluticasone 110 mcg two puffs inhaled b.i.d.\\n5. Salmeterol Diskus one inhalation b.i.d.\\n6. Acetaminophen 325-650 mg p.o. q.4-6h. prn.\\n7. Ipratropium bromide MDI two puffs inhaled q.2h. prn.\\n8. Albuterol 1-2 puffs inhaled q.2h. prn.\\n9. Zolpidem tartrate 5 mg p.o. q.h.s. prn.\\n10. Isosorbide dinitrate 10 mg p.o. t.i.d.\\n11. Diltiazem 60 mg p.o. q.i.d.\\n12. Pantoprazole 40 mg p.o. q.24h.\\n13. Trazodone 25 mg p.o. q.h.s. prn.\\n14. SubQ Heparin 5000 units subcutaneous b.i.d. until such\\ntime that the patient is able to get out of bed twice a day.\\n15. Cepacol lozenges q.2h. prn.\\n16. Levofloxacin 500 mg p.o. q.d. for a seven day course to\\nbe completed on [**2118-6-21**].\\n17. Kaopectate/Benadryl/lidocaine 5 mL p.o. b.i.d. prn, not\\nto be given around mealtimes for concern of dysphagia induced\\nby lidocaine.\\n18. Lorazepam 0.5-2 mg IV q.6h. prn.\\n\\nFOLLOW-UP PLANS:  The patient is recommended to followup with\\nDr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1407**], [**Telephone/Fax (1) 1408**] within two weeks of leaving\\nof the hospital.  She is also recommended to followup with\\nthe Interventional Pulmonary service for followup status post\\nstent placement.  She is also recommended to followup with a\\nneurologist if her muscle weakness does not improve within\\none week on physical therapy with concern for steroid-induced\\nmyopathy.\\n\\nFINAL DIAGNOSES:\\n1. Tracheomalacia status post tracheal and left main stem\\nbronchial stent placement.\\n2. Hypertension.\\n3. Hypothyroidism.\\n4. Restrictive lung defect.\\n5. Depression.\\n\\n\\n                     DR.[**Last Name (STitle) **],[**First Name3 (LF) **] 12-207\\n\\n\\nDictated By:[**Last Name (NamePattern1) 1811**]\\nMEDQUIST36\\n\\nD:  [**2118-6-14**]  11:30\\nT:  [**2118-6-14**]  11:33\\nJOB#:  [**Job Number 1812**]\\n</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>176</td>\n",
       "      <td>13702</td>\n",
       "      <td>167118.0</td>\n",
       "      <td>2119-05-25</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Discharge summary</td>\n",
       "      <td>Report</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Admission Date:  [**2119-5-4**]              Discharge Date:   [**2119-5-25**]\\n\\n\\nService: CARDIOTHORACIC\\n\\nAllergies:\\nAmlodipine\\n\\nAttending:[**Last Name (NamePattern1) 1561**]\\nChief Complaint:\\n81 yo F smoker w/ COPD, severe TBM, s/p tracheobronchoplasty [**5-5**]\\ns/p perc trach [**5-13**]\\n\\nMajor Surgical or Invasive Procedure:\\nbronchoscopy 3/31,4/2,3,[**6-12**], [**5-17**], [**5-19**]\\ns/p trachealplasty [**5-5**]\\npercutaneous tracheostomy [**5-13**] after failed extubation\\ndown size trach on [**5-25**] to size 6 cuffless\\n\\n\\nHistory of Present Illness:\\nThis 81 year old woman has a history of COPD. Over the past five\\n\\nyears she has had progressive difficulties with her breathing.\\nIn\\n[**2118-6-4**] she was admitted to [**Hospital1 18**] for respiratory failure\\ndue\\nto a COPD exacerbation. Due to persistent hypoxemia, she\\nrequired\\nintubation and a eventual bronchoscopy on [**2118-6-9**] revealed marked\\n\\nnarrowing of the airways on expiration consistent with\\ntracheomalacia.\\nShe subsequently underwent placement of two\\nsilicone stents, one in the left main stem and one in the\\ntrachea. During the admission the patient had complaints of\\nchest\\npain and ruled out for an MI. She was subsequently discharged to\\n\\n[**Hospital1 **] for physical and pulmonary rehab. Repeat bronchoscopy\\non\\n[**2118-8-1**] revealed granulation tissue at the distal right lateral\\nwall of the tracheal stent. There was significant malacia of the\\n\\nperipheral and central airways with complete collapse of the\\nairways on coughing and forced expiration. Small nodules were\\nalso noted on the vocal cords. She has noticed improvement in\\nher\\nrespiratory status, but most recently has been in discussion\\nwith Dr. [**First Name4 (NamePattern1) 951**] [**Last Name (NamePattern1) 952**] regarding possible tracheobronchial plasty\\n\\nwith mesh. Tracheal stents d/c [**2119-4-19**] in anticipation of\\nsurgery.\\nIn terms of symptoms, she describes many years of intermittent\\nchest pain that she describes as left sided and occurring at any\\n\\ntime. Currently, she notices it about three times a week, and\\nstates that it seems to resolve after three nitroglycerin.\\nShe currently is dependent on oxygen and wears 1.5-2 liters\\naround the clock. She has frequent coughing and brings up \"dark\\nsputum\".\\n\\n\\n\\nPast Medical History:\\nCOPD flare [**6-7**] s/p intubation, s/p distal tracheal to Left Main\\nStem stents placed [**2118-6-9**]. Stents d/c'd [**2119-4-19**], CAD w/ atypical\\nangina (LAD 30%, RCA 30%, EF 63%), ^chol, hypothyroidism, htn,\\nhiatal hernia, lacunar CVA, s/p ped struck -&gt; head injury &amp; rib\\nfx, depression\\nPMH:\\nCOPD, s/p admit [**6-7**] for exacerbation requiring intubation\\ntracheobronchomalacia, s/p bronchial stenting\\nLarge hiatal hernia\\nLacunar CVA\\nHypothyroidism by records in CCC, although patient denies and is\\n\\nnot taking any medication\\nDepression\\nMVA, s/p head injury approximately 10 years ago\\nHypertension\\nHysterectomy\\n\\n\\nSocial History:\\nSocial History: The patient is married and worked as a clinical\\npsychologist. Her husband is a pediatric neurologist at\\n[**Hospital3 **]. They have several children, one of which is\\n\\na nurse.\\n\\n\\nFamily History:\\nFamily History: (+) FHx CAD; Father with an MI in his 40's, died\\n\\nof a CVA at age 59\\n\\n\\nPhysical Exam:\\nAdmit H+P\\nGeneral-lovely 81 yr old feamle in NAD.\\nNeuro- intermittently anxious, MAE, PERRLA, L eye ptosis,\\nsymetrical smile, gossly intact.\\nHEENT-PERRLA, sclera anicteric, pharynx- no exud or erythema\\nResp-clear upper, diffuse ronchi, intermit exp wheezes\\nCor- RRR, No M, R, G\\nAbd- soft, NT, ND, no masses. Slight protrusion at area of\\nhiatal hernia\\nExt- no edema or clubbing\\n\\nBrief Hospital Course:\\n82 y/o female admitted [**2119-5-4**] for consideration of\\ntracheoplasty.\\nBronchoscopy done [**5-4**] confirming severe TBM. Underwent\\ntracheoplasty [**5-5**], complicated by resp failure d/t mucous\\nplugging, hypoxia requiring re-intubation resulting in prolonged\\nICU and hospital course. Also developed right upper extrem DVT\\nfrom mid line.\\n\\nPain- Epidural accidently d/c'd POD#1, pt briefly used dilaudid\\nPCA intermittently w/ fair pain control. Pt required\\nre-intubation for resp failure d/t secretions and PCA d/c at\\nthat time. Propofol for sedation while intubated. Sedation d/c'd\\n[**5-12**] for weaning trial w/ ETT- failed trial. Trach [**5-13**]-weaning\\nefforts as below. Minimal c/o pain since [**5-13**]. Presently pain\\nfree.\\n\\nNeuro- Initially intact- post op aggitation, inhibiting weaning\\nefforts [**5-16**]. Psych eval [**5-18**]-Started on zyprexa and ativan w/\\nimprovement in anxiety. Presently A+Ox3- cooperative and lovely.\\n\\nResp- Extubated POD#2 then required re-intub  [**5-7**] for hypoxia\\nd/t poor cough and mucous plugging. SIMV/PS alt w/CMV at night\\nx4-5d, with CPAP attempts during day.\\nBronchoscopy qd [**Date range (1) 1813**] for secretion management. Bronch [**5-9**]\\nrevealed swollen epiglottis, bronch [**5-10**] - good leak w/ ETT cuff\\ndeflated. Bronch [**5-13**] for eval/trach placement. Last bronch [**5-19**]\\nw/ min secretions present, sputum sent.\\n[**5-13**] perc trach done(#8 Portex- cuffed low pressure maintained to\\npreserve tracheoplasty site). [**5-13**] CPAP15/peep5 initiated post\\ntrach placement. Weaning ongoing.  [**Date range (1) 1814**]- Aggressive weaning\\nw/ increasing episodes of CPAP, progressing to Trach Mask.\\n[**2033-5-20**]-Trach mask overnight w/ no episodes of SOB, or\\nhemodynamic instability. Trach changed to #6 portex- capped and\\n[**Last Name (un) 1815**] well x48hrs on 2LNP. productive cough. Aggressive PT as\\nwell w/ OOB &gt; chair [**Hospital1 **]-tid to total 4-6hr qd. Ambulation\\n~100-120 ft [**5-22**] w/ PT assist.\\n\\nID- Vancomycin started post-op for graft prophylaxis. Fever\\nspike [**2119-5-8**] w/ BAl &amp; sputum sent&gt; + MRSA. Vanco cont to [**4-7**]\\nweeks post trachealplasty. Fever low grade [**5-12**], [**5-15**]&gt; cultured-\\nno new results. [**5-19**]- WBC 20.8 .\\n\\nCardiac-Hypertension controlled w/ hydralazine IV, then d/c and\\ncont controlled. HR 65-75 NSR. Avoiding B Blockers. Lasix 20mg\\nIV qd.\\n[**5-15**]- RUE redness and swelling at site of midline, RUE DVT by\\nultrasound, midline d/c; heparin gtt started and therapeutic\\nrange monitored. [**5-22**]  changed to Lovenox sq [**Hospital1 **]. Coags in good\\ncontrol [**5-23**] (48.2/13.8/1.2)\\nAccess- R midline placed [**2119-5-9**] for access- clotted [**2119-5-15**] and\\nd/c'd.  RUE redness and swelling and DVT via ultrasound. [**5-15**]- L\\nbrachial PICC line placed- TPN resumed.\\n\\nGI-Large hiatal hernia- unable to place enteral feeding tube at\\nbedside or underfluoro. Re-attempt [**5-17**] by EGD doboff tube\\nplaced distal esophagus, dislodged in 12hours and removed.\\n\\nNutrition- PPN/TPN initiated [**2119-5-8**]- [**2119-5-25**]. PICC placed\\n[**2119-5-15**]. Speech and Swallow eval [**5-22**]- rec change trach form #8\\nto #6 Portex to allow improved epiglotis and oropharyngeal\\nmovement to assist w/ swallowing. Then re-eval.  Trach changed\\n[**5-23**] to #6 cuffless portex trach. Passed repeat swallow eval and\\n[**Last Name (un) 1815**] diet of regular solids w/ thin liquids- CHIN TUCK to\\nswallow thin liquids. Give meds whole w/ apple sauce. WOULD\\nRECOMMEND repeat video swallow eval in [**8-17**] days to possibly\\neliminate chin tuck- see page 3 referral.\\n\\nEndo- Hypothyroid, maintained on levoxyl.\\n\\nMuscu/Skel- OOB&gt; chair 4-6hours/day, PT consulting.\\n\\n\\nMedications on Admission:\\nadvair 250/50\", atrovent, imdur 60', lasix 40', lexapro 20',\\nlipitor 10', prilosec 20', mucinex 600\", synthroid 75', detrol\\nLA 4', ambien 5', trazadone 75', melatonin prn\\n\\nDischarge Medications:\\n1. Albuterol Sulfate 0.083 % Solution Sig: One (1)  Inhalation\\nQ6H (every 6 hours) as needed for wheezing.\\n2. Ipratropium Bromide 0.02 % Solution Sig: One (1)  Inhalation\\nQ6H (every 6 hours) as needed for wheezing.\\n3. Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig:\\nOne (1) Disk with Device Inhalation [**Hospital1 **] (2 times a day).\\n4. Albuterol 90 mcg/Actuation Aerosol Sig: 1-2 Puffs Inhalation\\nQ6H (every 6 hours) as needed.\\n5. Ipratropium Bromide 18 mcg/Actuation Aerosol Sig: Two (2)\\nPuff Inhalation QID (4 times a day).\\n6. Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every\\n4 to 6 hours) as needed.\\n7. Sodium Chloride 0.65 % Aerosol, Spray Sig: [**2-5**] Sprays Nasal\\nQID (4 times a day) as needed.\\n8. Camphor-Menthol 0.5-0.5 % Lotion Sig: One (1) Appl Topical\\nTID (3 times a day) as needed.\\n9. Enoxaparin Sodium 60 mg/0.6mL Syringe Sig: One (1)\\nSubcutaneous Q12H (every 12 hours).\\n10. Trazodone HCl 50 mg Tablet Sig: 1.5 Tablets PO HS (at\\nbedtime) as needed.\\n11. Escitalopram Oxalate 10 mg Tablet Sig: Two (2) Tablet PO\\nDAILY (Daily).\\n12. Nystatin 100,000 unit/g Cream Sig: One (1) Appl Topical  [**Hospital1 **]\\n(2 times a day).\\n13. Pantoprazole Sodium 40 mg Tablet, Delayed Release (E.C.)\\nSig: One (1) Tablet, Delayed Release (E.C.) PO Q24H (every 24\\nhours).\\n14. Tolterodine Tartrate 2 mg Tablet Sig: One (1) Tablet PO BID\\n(2 times a day).\\n15. Levothyroxine Sodium 75 mcg Tablet Sig: One (1) Tablet PO\\nDAILY (Daily).\\n16. Heparin Lock Flush (Porcine) 100 unit/mL Syringe Sig: One\\n(1) ML Intravenous  DAILY (Daily) as needed.\\n\\n\\nDischarge Disposition:\\nExtended Care\\n\\nFacility:\\n[**Hospital3 7**] &amp; Rehab Center - [**Hospital1 8**]\\n\\nDischarge Diagnosis:\\nCOPD, Coronary Artery Disease/atypical angina (LAD 30%, RCA 30%,\\nEF 63%), hypercholesterolemia, hypothyroidism, Hypertension,\\nhiatal hernia, Cerebral Vascular Accident,s/p Motor Vehicle\\nColision-&gt; head injury &amp; rib fracture.\\nTBM- s/p tracheoplasty.\\n\\n\\nDischarge Condition:\\ngood\\n\\nDischarge Instructions:\\nplease update Dr.[**Name (NI) 1816**] [**Telephone/Fax (1) 170**] office for:  fever,\\nshortness of breath, chest pain , productive cough or if you\\nhave any questions or concerns.\\n\\n\\nCompleted by:[**2119-5-25**]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>177</td>\n",
       "      <td>13702</td>\n",
       "      <td>196489.0</td>\n",
       "      <td>2124-08-18</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Discharge summary</td>\n",
       "      <td>Report</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Admission Date:  [**2124-7-21**]              Discharge Date:   [**2124-8-18**]\\n\\n\\nService: MEDICINE\\n\\nAllergies:\\nAmlodipine\\n\\nAttending:[**First Name3 (LF) 898**]\\nChief Complaint:\\nCOPD exacerbation/Shortness of Breath\\n\\nMajor Surgical or Invasive Procedure:\\nIntubation\\narterial line placement\\nPICC line placement\\nEsophagogastroduodenoscopy\\n\\n\\nHistory of Present Illness:\\n87 yo F with h/o CHF, COPD on 5 L oxygen at baseline,\\ntracheobronchomalacia s/p stent, presents with acute dyspnea\\nover several days, and lethargy. This morning patient developed\\nan acute worsening in dyspnea, and called EMS. EMS found patient\\ntachypnic at saturating 90% on 5L. Patient was noted to be\\ntripoding. She was given a nebulizer and brought to the ER.\\n.\\nAccording the patient's husband, she was experiencing symptoms\\nconsistent with prior COPD flares. Apparently patient was\\nwithout cough, chest pain, fevers, chills, orthopnea, PND,\\ndysuria, diarrhea, confusion and neck pain. Her husband is a\\nphysician and gave her a dose of levaquin this morning.\\n.\\nIn the ED, patient was saturating 96% on NRB. CXR did not reveal\\nany consolidation. Per report EKG was unremarkable. Laboratory\\nevaluation revealed a leukocytosis if 14 and lactate of 2.2.\\nPatient received combivent nebs, solumedrol 125 mg IV x1,\\naspirin 325 mg po x1. Mg sulfate 2 g IV x1, azithromycin 500 mg\\nIVx1, levofloxacin 750 mg IVx1, and Cefrtiaxone 1g IVx1. Patient\\nbecame tachpnic so was trialed on non-invasive ventilation but\\nbecame hypotensive to systolics of 80, so noninvasive was\\nremoved and patient did well on NRB and nebulizers for about 2\\nhours. At that time patient became agitated, hypoxic to 87% and\\ntachypnic to the 40s, so patient was intubated. Post intubation\\nABG was 7.3/60/88/31. Propafol was switched to\\nfentanyl/midazolam for hypotension to the 80s. Received 2L of\\nNS. On transfer, patient VS were 102, 87/33, 100% on 60% 450 x\\n18 PEEP 5. Patient has peripheral access x2.\\n.\\nIn the ICU, patient appeared comfortable.\\n\\nReview of sytems:\\nlimited due to patient sedation\\n\\n\\nPast Medical History:\\n# COPD flare FEV1 40% in [**2120**], on 5L oxygen, s/p intubation\\n[**6-6**], s/p distal tracheal to Left Main Stem stents placed\\n[**2118-6-9**]. Stents d/c'd [**2119-4-19**]. Tracheobronchoplasty performed [**6-6**], [**2119**]\\n# CAD w/ atypical angina (cath [**2119**] - LAD 30%, RCA 30%, EF 63%)\\n# Dyslipidemia\\n# Hypothyroidism,\\n# Hypertension\\n# Hiatal hernia,\\n# lacunar CVA,\\n# s/p ped struck -&gt; head injury &amp; rib fx,\\n# depression\\n\\nSocial History:\\nThe patient is married and worked as a clinical\\npsychologist. Her husband is a pediatric neurologist at\\n[**Hospital3 **]. They have several children, one of which is\\na nurse. [**First Name (Titles) 1817**] [**Last Name (Titles) 1818**] with 40 pack years, quit 5 years ago.\\nSocial ethanol user. No history of IVDU, but remote history of\\nmarijuana use.\\n\\nFamily History:\\n(+) FHx CAD; Father with an MI in his 40's, died\\nof a CVA at age 59\\n\\nPhysical Exam:\\nOn admission\\nVitals: T: BP: 116/46 P: 92 O2: 100%\\nTV 60% 450 x 18 PEEP 5\\nGeneral: Intubated, sedated, no apparent discomfort\\nHEENT: Sclera anicteric, MMM, oropharynx clear\\nNeck: supple, JVP not elevated, no LAD\\nLungs: crackles bases bilaterally\\nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs,\\ngallops\\nAbdomen: soft, non-tender, non-distended, bowel sounds present,\\nno rebound tenderness or guarding, no organomegaly\\nGU: no foley\\nExt: warm, well perfused, 2+ pulses, no clubbing, cyanosis or\\nedema\\n\\n\\nPertinent Results:\\nInitial Labs\\n[**2124-7-21**] 10:55AM BLOOD WBC-14.1*# RBC-4.20# Hgb-12.6# Hct-39.1#\\nMCV-93 MCH-30.1 MCHC-32.3 RDW-12.6 Plt Ct-319\\n[**2124-7-21**] 10:55AM BLOOD Neuts-93.9* Lymphs-4.4* Monos-1.3*\\nEos-0.2 Baso-0.2\\n[**2124-7-22**] 03:50AM BLOOD PT-11.0 PTT-28.7 INR(PT)-0.9\\n[**2124-7-21**] 10:55AM BLOOD Glucose-168* UreaN-13 Creat-0.8 Na-140\\nK-3.5 Cl-92* HCO3-36* AnGap-16\\n[**2124-7-22**] 03:50AM BLOOD Calcium-8.8 Phos-3.4 Mg-2.1\\n\\nCardiac Biomarkers\\n[**2124-7-21**] 10:55AM BLOOD CK(CPK)-321* cTropnT-0.02*\\n[**2124-7-21**] 06:25PM BLOOD CK(CPK)-345* CK-MB-14* MB Indx-4.1\\ncTropnT-0.01\\n[**2124-7-22**] 03:50AM BLOOD CK(CPK)-845* CK-MB-15* MB Indx-1.8\\ncTropnT-0.01\\n[**2124-7-22**] 12:04PM BLOOD CK(CPK)-1030* CK-MB-15* MB Indx-1.5\\ncTropnT-0.01\\n[**2124-7-23**] 03:15AM BLOOD CK(CPK)-530* CK-MB-9 cTropnT-0.01\\nproBNP-2535*\\n\\nCXR ([**2124-7-21**]) - IMPRESSION: Hiatal hernia, otherwise\\nunremarkable. Limited exam.\\n\\nEcho ([**2124-7-24**]) - There is mild symmetric left ventricular\\nhypertrophy with normal cavity size and regional/global systolic\\nfunction (LVEF&gt;55%). The estimated cardiac index is normal\\n(&gt;=2.5L/min/m2). Tissue Doppler imaging suggests an increased\\nleft ventricular filling pressure (PCWP&gt;18mmHg). Right\\nventricular chamber size is normal. with normal free wall\\ncontractility. The aortic valve leaflets (3) are mildly\\nthickened but aortic stenosis is not present. No aortic\\nregurgitation is seen. The mitral valve leaflets are mildly\\nthickened. There is no mitral valve prolapse. Mild (1+) mitral\\nregurgitation is seen. The tricuspid valve leaflets are mildly\\nthickened. There is moderate pulmonary artery systolic\\nhypertension. There is an anterior space which most likely\\nrepresents a prominent fat pad.\\nIMPRESSION: Normal biventricular systolic function. Moderate\\npulmonary artery systolic hypertension.\\n\\nCXR ([**2124-8-5**]) - Kyphotic positioning. Compared with one day\\nearlier and allowing for technical differences, the right-sided\\neffusion may be slightly larger. Otherwise, no significant\\nchange is detected. Again seen is retrocardiac opacity\\nconsistent with left lower lobe collapse and/or consolidation\\nand a small left effusion. As noted, a right effusion is again\\nseen, possibly slightly larger on the current examination, with\\nunderlying collapse and/or consolidation. Doubt CHF.\\nDegenerative changes of the thoracic spine are noted.\\n\\nCardiac Enzymes [**2124-8-12**]: Trop&lt;0.01\\n                [**2124-8-13**]: Trop 0.03\\n                [**2124-8-14**]: Trop 0.02\\n\\nLABS AT DISCHARGE:\\n\\n[**2124-8-16**] 05:40AM BLOOD WBC-9.5 RBC-3.08* Hgb-9.6* Hct-28.3*\\nMCV-92 MCH-31.2 MCHC-33.9 RDW-13.5 Plt Ct-360\\n[**2124-8-16**] 05:40AM BLOOD PT-10.4 PTT-22.8 INR(PT)-0.8*\\n[**2124-8-17**] 05:30AM BLOOD Glucose-114* UreaN-18 Creat-0.8 Na-142\\nK-3.5 Cl-101 HCO3-36* AnGap-9\\n[**2124-8-16**] 05:40AM BLOOD Calcium-8.9 Phos-2.8 Mg-2.3\\n[**2124-8-16**] 05:40AM BLOOD TSH-0.87\\n\\nBrief Hospital Course:\\n87 yo F with h/o CHF, COPD on 5 L oxygen at baseline,\\ntracheobronchomalacia s/p stent, presents with acute dyspnea\\nover several days, no s/p intubation for hypercarbic respiratory\\nfailure.\\n\\n# Hypercarbic respiratory failure: Presents with dyspnea, but no\\nclear cough or fevers. Per report, patient felt like this with\\nprior COPD exacerbations. Leukocytosis supports possible\\npneumonia, but history and CXR not entirely consistent with\\nthis. EKG with signs of demand, but ROMI negative. Sputum gram\\nstain unremarkable, but respitatory viral culture grew\\nparainfluenze type 3 on [**7-24**]. Patient was initially managed on\\nsolumedrol 60 mg IV Q8H, and was eventually tapered. With no\\nevidence of pneumonia on CXR and sputum gram stain, antibiotics\\nwere stopped [**7-25**]. Beta-agonists and anticholinergics were\\ncontinued around the clock. TTE revealed mild symmetric lvh with\\nnormal ef, increased pcwp (&gt;18mmHg), Normal RV, and moderate\\npulmonary artery systolic hypertension. On [**7-26**], bronchoscopy\\nrevealed collapsible, unremarkable airways. Patient had\\ndifficulty weaning from the vent, and would become\\ninterimittenty hypertensive to SBP 200s and tachypnic to the\\n50s. Patient was extubatied on [**7-27**] after passing SBT 0/5, but\\nrequired re-intubation 30 minutes later for worsening\\nsecretions, lack of gag reflex, and tachypnea to the 50s. Of\\nnote, on [**8-1**], the patient was found to have MRSA growing in\\nsputum samples. Although it was felt that this likely\\nrepresented colonization as opposed to true infection, the\\npatient was started on a course of vancomycin (which was stopped\\nafter 5 days). After multiple discussions between the patient's\\nfamily and the ICU team, the patient's PCP, [**Name10 (NameIs) **] the palliative\\ncare service, the patient's family ultimately decided that she\\nwould not want a tracheostomy. On [**2124-8-3**], extubation was pursued\\nagain and was successful. After extubation, her respiratory\\nstatus improved and she was ultimately called out to the medical\\nfloor. On the floor she was progressively weaned to 2LNC with\\nnebs (better than her baseline 5L @home). Because of clinical\\nexams revealing mild volume overload, she was intermittently\\ndiuresed. She also experienced intermittent shortness of breath\\nwith tachypnea but this was thought to be the result of attacks\\nof anxiety with tachypnea. After receiving prn morphine, her\\nbreathing status would typically improve. A steroid taper was\\nbegun. The patient should continue prednisone 30 mg daily for 3\\nmore days, then 20 mg daily for 4 days, then 10 mg daily for 4\\ndays, then 5 mg daily for 4 days, then stop.\\n.\\n# Upper GI bleeding: On [**7-22**], patient had coffee grounds from OG\\ntube. Lavage for approx 600ccs with clearance. GI perfomred EGD\\nwhich revealed esophagitis, ulcers and blood in the stomach\\nbody, D2 diverticulum and large hiatal hernia. H pylori was\\nnegative. Patient was continued on IV PPI, with plan for repeat\\nEGD in 8 weeks, and upper GI series once clinically improved\\ngiven abnormal anatomy on EGD. Her hematocrit remained stable\\nwith no further episodes of upper GI bleeding throughout the\\npatient's hospitalization. On the floor she was switched to PO\\npantoprazole twice daily. Aspirin was held.\\n.\\n# Weakness: The patient was found to have generalized weakness\\nat the end of her hospitalization. Neurology was consulted and\\nthey felt it was likely due to a combination of steroid myopathy\\nand deconditioning from her prolonged bedbound status. A TSH was\\nchecked which was normal. They recommended pulmonary and\\nphysical rehab.\\n.\\n# CAD: History of LAD and RCA stenosis on Cath, but no stents.\\nContinued statin and beta blocker, but held aspirin for GI\\nbleeding (see above)\\n.\\n# Nutrition: Unable to pass NG without direct visualization due\\nto hiatal hernia. IR guided post pyloric NG tube was placed on\\n[**7-26**] for TFs and po medications. NG tube was pulled when patient\\nwas extubated on [**2124-8-3**]. Speech and swallow were consulted\\nfollowing the patient's extubation and she was eventually moved\\nto soft solids and thin liquids with 1:1 supervision.\\n\\n# Goals of care: PCP [**Last Name (NamePattern4) **]. [**Last Name (STitle) 1407**] was very involved in discussions\\nregarding patient's code status. Palliative care also followed\\nalong with the patient. Ultimately, at the time of the patient's\\nextubation on [**2124-8-3**], it was decided that the patient would be\\nDNR/DNI (although this was later change). The patient's family\\nfelt that she would not want a tracheostomy. It was decided that\\nshe would not be reintubated and that, if her respiratory status\\nwere to worsen after intubation, care would be focused on\\ncomfort. However, her status improved in the MICU and on the\\nfloor and it was then decided that she would remain DNR with\\nintubation (but no tracheostomy) if her breathing deteriorated.\\nAfter several days with stable or improved overall clinical\\nstatus, she was deemed suitable for rehabilitation. At the timem\\nof discharge, the patient's code status was do not resuscitate,\\nokay to intubate.\\n\\nMedications on Admission:\\n# Omeprazole 20 mg daily\\n# Furosemide 20 mg daily\\n# Toprol XL 50 mg daily\\n# Lipitor 20 mg daily\\n# Folic Acid 1 mg daily\\n# Centrum daily\\n# Diovan 80 mg daily\\n# Trazodone 75-100 mg qhs\\n# Melatonin 3 mg qhs\\n# [**Doctor Last Name 1819**] Aspirin 325 mg daily\\n# Albuterol neb prn\\n# Duoneb prn\\n# Advair 250/50 [**Hospital1 **]\\n# Zolpidem 2.5 mg qhs prn\\n# Synthroid 100 mcg daily\\n# Lexapro 20 mg daily\\n\\n\\nDischarge Medications:\\n1. Metoprolol Succinate 50 mg Tablet Sustained Release 24 hr\\nSig: One (1) Tablet Sustained Release 24 hr PO once a day.\\n2. Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY\\n(Daily).\\n3. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).\\n\\n4. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily).\\n\\n5. Trazodone 50 mg Tablet Sig: One (1) Tablet PO at bedtime as\\nneeded for insomnia.\\n6. Melatonin 3 mg Tablet Sig: One (1) Tablet PO at bedtime.\\n7. Valsartan 160 mg Tablet Sig: 1.5 Tablets PO once a day.\\n8. Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for\\nNebulization Sig: One (1) neb Inhalation every 4-6 hours as\\nneeded for shortness of breath or wheezing.\\n9. DuoNeb 0.5 mg-3 mg(2.5 mg base)/3 mL Solution for\\nNebulization Sig: One (1) neb Inhalation every six (6) hours as\\nneeded for shortness of breath or wheezing.\\n10. Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig:\\nOne (1) puff Inhalation twice a day.\\n11. Escitalopram 10 mg Tablet Sig: Two (2) Tablet PO DAILY\\n(Daily).\\n12. Levothyroxine 100 mcg Tablet Sig: One (1) Tablet PO DAILY\\n(Daily).\\n13. Prednisone 20 mg Tablet Sig: One (1) Tablet PO daily () for\\n4 days: Start after 3 days of 30 mg daily.\\n14. Prednisone 10 mg Tablet Sig: One (1) Tablet PO daily () for\\n4 days: Start after 4 days of 20 mg daily.\\n15. Prednisone 5 mg Tablet Sig: One (1) Tablet PO daily () for 4\\ndays: Start after 4 days of 10 mg daily.\\n16. Hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO\\nDAILY (Daily).\\n17. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One\\n(1) Tablet, Delayed Release (E.C.) PO twice a day.\\n18. Morphine 10 mg/5 mL Solution Sig: Five (5) mg PO every four\\n(4) hours as needed for respiratory discomfort: Hold for\\noversedation or RR&lt;12.\\n19. Prednisone 10 mg Tablet Sig: Three (3) Tablet PO once a day\\nfor 3 days.\\n20. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day.\\n21. Senna 8.6 mg Tablet Sig: One (1) Tablet PO twice a day as\\nneeded for constipation.\\n22. Humalog insulin sliding scale\\nPlease use attached Humalog insulin sliding scale while on\\nsteroids.\\n\\n\\nDischarge Disposition:\\nExtended Care\\n\\nFacility:\\n[**Location 1820**] center at [**Location (un) 1821**]\\n\\nDischarge Diagnosis:\\nPrimary:\\n1. Chronic Obstructive Pulmonary Disease Exacerbation\\n2. Respiratory failure with intubation\\n3. Upper gastrointestinal bleed/Peptic Ulcer Disease\\n4. Hypertension\\n5. Anxiety\\n\\nSecondary:\\n1. Coronary Artery Disease\\n2. Hypothyroidism\\n\\n\\nDischarge Condition:\\nMental Status: Confused - sometimes.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Out of Bed with assistance to chair or\\nwheelchair.\\n\\n\\nDischarge Instructions:\\nYou were admitted to the hospital with shortness of breath and\\nrespiratory failure and lethargy. In the emergency department,\\nyou were breathing very fast and a breathing tube was inserted\\ninto your airway to help you breathe. You were admitted to the\\nintensive care unit. There, you were managed with steroids and\\nantibiotics and the tube was eventually removed from your\\nairway, allowing you to breathe on your own. You also underwent\\nbronchoscopy which looked at the inside of your airways.\\n.\\nDuring your time in the intensive care unit, you developed a\\ngastrointestinal bleed. A tube was placed into your stomach and\\nyou underwent an endoscopic procedure to look at your esophagus\\nand stomach. This showed inflammation in your esophagusand\\nulcers in your stomach.\\n.\\nYou should continue to use nasal oxygen by nasal cannula as\\nneeded. You should continue the steroid taper as instructed. You\\nshould call your doctor or return to the emergency room if you\\nhave increasing difficulty breathing or shortness of breath,\\nwheezing, chest pain, blood in your stool or vomiting blood.\\n.\\nThere are some changes in your medications.\\nSTART pantoprazole 40 mg twice daily and STOP omeprazole\\nSTART hydrochlorothiazide\\nSTART prednisone, taking 30 mg for 3 days, then 20 mg for 4\\ndays, then 10 mg for 4 days, then 5 mg for 4 days, then stop.\\nSTART colace and senna as needed for constipation\\nCan use morphine to alleviate symptoms of respiratory discomfort\\nSTOP furosemide\\nSTOP zolpidem\\nSTOP aspirin\\nINCREASE Diovan to 240 mg daily\\nDECREASE trazodone to 50 mg daily\\n.\\nFollow up as indicated below.\\n\\nFollowup Instructions:\\nYou have an appointment to follow up with Dr. [**Last Name (STitle) 1407**], your\\nprimary care physician, [**Name10 (NameIs) **] [**8-29**] at 1pm. His address is [**Location (un) 1822**], [**Apartment Address(1) 1823**], [**Location (un) **],[**Numeric Identifier 1700**]. The phone is\\n[**Telephone/Fax (1) 1408**].\\n\\nYou have an appointment to follow up with Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 174**] in\\nthe  [**Hospital **] clinic on [**8-30**] at 3pm in the [**Hospital Unit Name 1824**] at [**Hospital1 18**] on the [**Location (un) 453**]. Their phone number is\\n[**Telephone/Fax (1) 463**].\\n\\nDepartment: DIV. OF GASTROENTEROLOGY\\nWhen: WEDNESDAY [**2124-8-30**] at 3:00 PM\\nWith: [**First Name4 (NamePattern1) 1386**] [**Last Name (NamePattern1) **], MD [**Telephone/Fax (1) 463**]\\nBuilding: Ra [**Hospital Unit Name 1825**] ([**Hospital Ward Name 1826**]/[**Hospital Ward Name 1827**] Complex) [**Location (un) **]\\nCampus: EAST     Best Parking: Main Garage\\n\\n\\n\\n</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>178</td>\n",
       "      <td>26880</td>\n",
       "      <td>135453.0</td>\n",
       "      <td>2162-03-25</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Discharge summary</td>\n",
       "      <td>Report</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Admission Date:  [**2162-3-3**]              Discharge Date:   [**2162-3-25**]\\n\\nDate of Birth:  [**2080-1-4**]             Sex:   M\\n\\nService: MEDICINE\\n\\nAllergies:\\nPatient recorded as having No Known Allergies to Drugs\\n\\nAttending:[**First Name3 (LF) 1828**]\\nChief Complaint:\\nMr. [**Known lastname 1829**] was seen at [**Hospital1 18**] after a mechanical fall from\\na height of 10 feet.  CT scan noted unstable fracture of C6-7 &amp;\\nposterior elements.\\n\\nMajor Surgical or Invasive Procedure:\\n1. Anterior cervical osteotomy, C6-C7, with decompression and\\nexcision of ossification of the posterior longitudinal ligament.\\n2. Anterior cervical deformity correction.\\n3. Interbody reconstruction.\\n4. Anterior cervical fusion, C5-C6-C7.\\n5. Plate instrumentation, C5-C6-C7.\\n6. Cervical laminectomy C6-C7, T1.\\n7. Posterior cervical arthrodesis C4-T1.\\n8. Cervical instrumentation C4-T1.\\n9. Arthrodesis augmentation with autograft, allograft and\\ndemineralized bone matrix.\\n\\n\\nHistory of Present Illness:\\nMr. [**Known lastname 1829**] is a 82 year old male who had a slip and fall\\nof approximately 10 feet from a balcony.  He was ambulatory at\\nthe scene.  He presented to the ED here at [**Hospital1 18**].  CT scan\\nrevealed unstable C spine fracture.  He was intubated secondary\\nto agitation.\\n\\nPatient admitted to trauma surgery service\\n\\nPast Medical History:\\nCoronary artery disease s/p CABG\\nCHF\\nHTN\\nAICD\\nAtrial fibrillation\\nStroke\\n\\nSocial History:\\nPatient recently discharged from [**Hospital1 **] for severe\\ndepression. Family reports patient was very sad and attempted to\\nkill himself by wrapping a telephone cord around his neck. Lives\\nwith his elderly wife, worked as a chemist in [**Country 532**].\\n\\nFamily History:\\nNon contributory\\n\\nPhysical Exam:\\nPhycial exam prior to surgery was not obtained since patient was\\nintubated and sedated.\\n\\nPost surgical physical exam: (TSICU per surgery team)\\n\\nBreathing without assistance\\nNAD\\nVitals: T 97.5, HR 61, BP 145/67, RR22, SaO2 98\\nA-fib, rate controlled\\nAbd soft non-tender\\nAnterior/Posterior cervical incisions [**Name (NI) 1830**]\\nPt is edemitous in all four extremities, no facial edema\\nAble to grossly move all four extremities, neurointact to light\\ntouch\\nDistal pulses weakly intact\\n\\nMedicine Consult:\\nVS: Tm/c 98.9 142/70 61 20 96%RA\\nI/O BM yesterday 220/770\\nGen: awake, calm, cooperative and pleasant, lying in bed\\nNeck: c-collar removed\\nCV: irregular, normal S1, S2. No m/r/g.\\nlungs: cta anteriolry\\nAbd: Obese, Soft, NTND, decreased bs\\nExt: trace b/l le edema, 1+ UE edema\\nneuro/cognition: thought [**3-17**], \"8\", not to place,\\n\\n\\nPertinent Results:\\n====================\\n ADMISSION LABS\\n====================\\n\\nWBC-8.4 RBC-4.43* Hgb-11.9* Hct-38.6* MCV-87 MCH-26.9*\\nMCHC-30.9* RDW-17.3* Plt Ct-191\\nPT-20.4* PTT-28.1 INR(PT)-1.9*\\nCK(CPK)-183* Amylase-70\\nCalcium-8.5 Phos-2.0* Mg-1.9\\nGlucose-121* Lactate-2.3* Na-140 K-4.3 Cl-101 calHCO3-26\\n\\n==================\\n   RADIOLOGY\\n==================\\n\\nCT scan C spine [**2162-3-3**]:\\nIMPRESSION:\\n1.  Fracture of the C6 as described involving the right pedicle\\n(extending to the inferior facet) and left lamina. Anterior\\nwidening at the C6-7 disc space and mild widening of left C6-7\\nfacet also noted. Prevertebral hematoma at C6 with likely\\nrupture of the anterior longitudinal ligament.\\n\\n2.  Lucency in the right posterior C1 ring may represent a\\nchronic injury.\\nLikely old avulsion fracture at T2 pedicle on the left.\\n\\n3. Ossification of both anterior and posterior longitudinal\\nligaments with\\ncompromise of the central spinal canal. Degenerative disease is\\nfurther\\ndescribed above.\\n\\nCT ABDOMEN/PELVIS ([**2162-3-3**])\\nIMPRESSION:\\n1. No acute injuries in the chest, abdomen, or pelvis.\\n2. Three discrete pleural fluid collections in the right\\nhemithorax, likely pseudotumors.\\n3. Small hypodense lesion in the pancreatic body is of unclear\\netiology, may represent pseudicyst or cystic tumor. Further\\nevaluation with MRI may be performed on a non- emergent basis.\\n4. Bilateral renal cysts.\\n5. Foley catheter balloon inflated within the prostatic urethra.\\nRecommend emergent repositioning.\\n\\nCT SINUS/MAXILLOFACIAL ([**2162-3-3**])\\n1. Bilateral nasal bone fractures.\\n2. Left frontal scalp hematoma with preseptal soft tissue\\nswelling. Question foreign body anterior to the left globe.\\nRecommend clinical correlation. Small amount of extraconal\\nhematoma in the superior aspect of the left orbit.\\n3. Linear lucency in the right posterior ring of C1. Correlate\\nwith CT C- spine performed concurrently.\\n\\nHEAD CT ([**2162-3-3**])\\n1. No acute intracranial hemprrhage.\\n2. Left frontal scalp hematoma.\\n3. Nasal bone fractures. Recommend correlation with report from\\nfacial bone CT scan.\\n4. Lucency in the right posterior ring of C1. Please refer to\\ndedeicated CT C-spine for further detail.\\n5. Left cerebellar encephalomalacia, likely due to old\\ninfarction.\\n\\nCHEST [**2162-3-10**]\\nThe Dobbhoff tube passes below the diaphragm with its tip most\\nlikely terminating in the stomach. The bilateral pacemakers are\\ndemonstrated with one lead terminating in right atrium and three\\nleads terminating in right ventricle. The patient is in mild\\npulmonary edema with no change in the loculated pleural fluid\\nwithin the major fissure.\\n\\nCT HEAD [**2162-3-11**]\\n1. A tiny amount of intraventricular hemorrhage layers along the\\noccipital horns of the ventricles bilaterally. Recommend followp\\nimaging.\\n2. Left frontal scalp hematoma has decreased in size.\\n3. Unchanged left cerebellar encephalomalacia.\\n4. Nasal bone fractures are better evaluated on dedicated\\nmaxillofacial CT.\\n\\nRIGHT SHOULDER X-RAY ([**2162-3-11**])\\nMild glenohumeral and acromioclavicular joint osteoarthritis.\\nNonspecific ossification projecting over the upper margin of the\\nscapular body and adjacent to the lesser tuberosity. Diagnostic\\nconsiderations include the sequela of chronic calcific bursitis,\\nintraarticular bodies, and/or calcific tendinitis of the\\nsubscapularis tendon.\\nIncreased opacity projecting over the right hemithorax and minor\\nfissure, better delineated on recent chest radiographs and chest\\nCT\\n\\nRIGHT UPPER EXTREMITY ULTRASOUND ([**2162-3-13**])\\n1. Deep venous thrombosis in the right axillary vein, extending\\nproximally into the right subclavian vein, and distally to\\ninvolve the brachial veins, portion of the basilic vein, and the\\nright cephalic vein.\\n2. Likely 2.0 cm left axillary lymph node, with unusual\\nson[**Name (NI) 493**] features somewhat suspicious for malignancy.\\nFollowup ultrasound is recommended in 4 weeks, and FNA/biopsy\\nmay be considered at that time if no interval improvement.\\n\\n[**2162-3-14**]\\nCT ABDOMEN WITH IV CONTRAST: There are small-to-moderate\\nbilateral pleural effusions, on the right with a loculated\\nappearance. There is associated compressive atelectasis. The\\nvisualized portion of the heart suggests mild cardiomegaly.\\nThere is no pericardial effusion. There is a 9-mm\\nhypoattenuating, well-defined lesion in the left lobe of the\\nliver (2:12) too small to accurately characterize but\\nstatistically most likely representing a cyst. There are\\nbilateral, partially exophytic renal cysts. The spleen is normal\\nin size. There is a 5-mm hypoattenuating focus in the pancreatic\\nbody, most likely representing focal fat. The gallbladder and\\nadrenal glands are unremarkable. An NG tube terminates in the\\nstomach. There is no ascites. The large and small bowel loops\\nappear unremarkable without wall thickening or pneumatosis. Oral\\ncontrast material has passed into the ascending colon without\\nevidence of obstruction. There is no ascites and no free air.\\nThere is a small pocket of air in the left rectus muscle,\\ntracking over a distance of approximately 10 cm.\\n\\nCT PELVIS WITH IV CONTRAST: The pelvic small and large bowel\\nloops, collapsed bladder containing Foley catheter and seminal\\nvesicles appear unremarkable. The prostate is enlarged,\\nmeasuring 5.9 cm in transverse diameter. The rectum contains a\\nmoderate amount of dried stool. There is no free air or free\\nfluid.\\n\\nBONE WINDOWS: No suspicious lytic or sclerotic lesions. There is\\nDISH of the entire visualized thoracolumbar spine. There also\\nare degenerative changes about the hip joints with large\\nacetabular osteophytes.\\n\\nIMPRESSION:\\n1. Stable bilateral pleural effusions, loculated on the right.\\n2. New focus of air tracking within the left rectus muscle with\\nassociated tiny amount of extraperitoneal air (2:53). No\\nassociated stranding or fluid collection. Please correlate\\nclinically if this could be iatrogenic, such as due to s.q.\\ninjections.\\n3. 5-mm hypoattenuating focus in the pancreatic body. This could\\nrepresent focal fat, although a cystic tumor cannot be excluded.\\nIf this is of concern, then MRI is again recommended for further\\nevaluation.\\n4. Hypoattenuating focus in the left lobe of the liver, too\\nsmall to accurately characterize.\\n5. Bilateral partially exophytic renal cysts.\\n6. Moderate amount of dried stool within the rectum.\\n\\nA wet read was placed and the pertinent findings were discussed\\nby Dr. [**First Name (STitle) 1831**] [**Name (STitle) 1832**] with Dr. [**First Name (STitle) 1833**] at 11:30 p.m. on [**2162-3-14**].\\n\\n[**2162-3-16**]\\nVIDEO OROPHARYNGEAL SWALLOW FINDINGS: Real-time video\\nfluoroscopic evaluation was performed after oral administration\\nof thin and puree consistency of barium, in conjunction with the\\nspeech pathologist.\\n\\nORAL PHASE: Normal bolus formation, bolus control, AP tongue\\nmovement, oral transit time, and no oral cavity residue.\\n\\nPHARYNGEAL PHASE: There is normal swallow initiation and velar\\nelevation. There is mild-to-moderate impairment of laryngeal\\nelevation with absent epiglottic deflection. There is\\nmoderate-to-severe increase in pharyngeal transit time. There is\\nresidue in the valleculae and piriform sinuses with moderate\\nimpairment of bolus propulsion. There was aspiration of both\\nthin and puree barium.\\n\\nIMPRESSION: Aspiration of thin liquids and puree. For additional\\ninformation, please see the speech and swallow therapist's\\nreport from the same day.\\n\\n[**2162-3-18**] CT Head w/out:\\nFINDINGS: There is a small amount of blood layering in the\\noccipital horns of both lateral ventricles, unchanged though not\\nas dense given evolution. No new hemorrhage is identified. The\\nventricles, cisterns, and sulci are enlarged secondary to\\ninvolutional change. Periventricular white matter hyperdensities\\nare sequelae of chronic small vessel ischemia. Encephalomalacia\\nin the left cerebellar hemisphere secondary to old infarction is\\nunchanged. The osseous structures are unremarkable. The\\nvisualized paranasal sinuses and mastoid air cells are clear.\\nSkin staples are noted along the superior- posterior neck\\nsecondary to recent spinal surgery.\\n\\nIMPRESSION: No interval change with a very small\\nintraventricular hemorrhage.\\n\\nNo discharge labs as patient CMO.\\n\\nBrief Hospital Course:\\nMr. [**Known lastname 1829**] was seen at [**Hospital1 18**] after his fall from a height\\nof approximatly 10 feet.  CT scans of his chest, abdomen and\\npelvis were negative for pathology.  CT scan of his C-spine\\nshowed fracture of anterior and posterior elements at C6-7.  He\\nwas also shown to have a right nasal bone fracture.\\n\\nC-spine fracture: Mr. [**Known lastname 1829**] [**Last Name (Titles) 1834**] two surgical\\nprocedures to stabilized his c-spine.  [**2162-3-4**]: anterior\\ncervical decompression/fusion at C6-7.  [**2162-3-5**]: Cervical\\nlaminectomy C6-C7 &amp; T1 with Posterior cervical arthrodesis\\nC4-T1.  He tolerated the procedures well.  He was extubated\\nwithout complication.\\n\\nAfter his surgical procedures, Mr. [**Known lastname 1829**] was transfered\\nto the medicine service at [**Hospital1 18**] for his medical care. While on\\nthe medicine service, patient was found to be persistently\\naspirating and failed his speech and swallow evaluation. Patient\\nand family were not interested in an NG tube or PEG for\\nnutrition. Patient also developed a venous clot of the right\\nupper extremity and the decision was made to not proceed with\\nmedical treatment. Goals of care were changed to comfort\\nmeasures only. A foley was placed after patient had difficulty\\nwith urinary retention and straight cathing. A palliative care\\nconsult was obtained for symptom management and patient was\\ndischarged to hospice with morphine, olanzapine, and a foley in\\nplace for symptomatic relief.\\n\\nMedications on Admission:\\nCoumadin\\nseroquel\\ndocusate\\nmetoprolol\\nfolate\\nlovastatin\\ncaptopril\\nASA\\nipratroium inhaler\\nFerrous sulfate\\nfurosemide\\ncitalopram\\nisosorbide\\nmeprazole\\n\\nDischarge Medications:\\n1. Bisacodyl 10 mg Suppository Sig: [**12-30**] Suppositorys Rectal\\nDAILY (Daily) as needed for constipation.\\n2. Ipratropium Bromide 0.02 % Solution Sig: One (1) nebulizer\\nInhalation Q6H (every 6 hours) as needed for wheezing.\\n3. Albuterol Sulfate 2.5 mg/3 mL Solution for Nebulization Sig:\\nOne (1) solution Inhalation Q6H (every 6 hours) as needed for\\nwheezing.\\n4. Morphine Concentrate 20 mg/mL Solution Sig: 5-10 mg PO Q4H\\n(every 4 hours) as needed for pain: may shorten interval as\\nneeded to control pain.\\n5. Olanzapine 5 mg Tablet, Rapid Dissolve Sig: 0.5 Tablet, Rapid\\nDissolve PO QHS (once a day (at bedtime)) as needed for\\nagitation.\\n6. Tamsulosin 0.4 mg Capsule, Sust. Release 24 hr Sig: One (1)\\nCapsule, Sust. Release 24 hr PO DAILY (Daily): may be\\ndiscontinued if patient not tolerating pills or refusing to\\ntake.\\n\\n\\nDischarge Disposition:\\nExtended Care\\n\\nFacility:\\n[**Hospital1 599**] of [**Location (un) 55**]\\n\\nDischarge Diagnosis:\\n1. Cervical spondylosis with calcification of posterior\\nlongitudinal ligament.\\n2. Fracture dislocation C6-C7.\\n3. Ossification of the posterior longitudinal ligament.\\n4. Aspiration Pneumonia\\n\\n\\n1. Cervical spondylosis with calcification of posterior\\n    longitudinal ligament.\\n2. Fracture dislocation C6-C7.\\n3. Ossification of the posterior longitudinal ligament.\\n4. Aspiration Pneumonia\\n\\n1. Cervical spondylosis with calcification of posterior\\n    longitudinal ligament.\\n2. Fracture dislocation C6-C7.\\n3. Ossification of the posterior longitudinal ligament.\\n4. Aspiration Pneumonia\\n\\n\\nDischarge Condition:\\nStable to outside facility\\n\\n\\nDischarge Instructions:\\nPatient has been made CMO at the request of him and his family.\\nHe has a foley placed for urinary retention. Please use morphine\\nas needed for pain and olanzapine as needed for agitiation.\\nPatient has known history of aspiration documented on speech and\\nswallow. It is the patient and the family's wish for him to\\ncontinue to eat and drink as desired.\\n\\nFollowup Instructions:\\nFollow up with your primary care physician as needed.\\n\\n\\n\\n</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   ROW_ID  SUBJECT_ID   HADM_ID   CHARTDATE CHARTTIME STORETIME  \\\n",
       "0     174       22532  167853.0  2151-08-04       NaN       NaN   \n",
       "1     175       13702  107527.0  2118-06-14       NaN       NaN   \n",
       "2     176       13702  167118.0  2119-05-25       NaN       NaN   \n",
       "3     177       13702  196489.0  2124-08-18       NaN       NaN   \n",
       "4     178       26880  135453.0  2162-03-25       NaN       NaN   \n",
       "\n",
       "            CATEGORY DESCRIPTION  CGID  ISERROR  \\\n",
       "0  Discharge summary      Report   NaN      NaN   \n",
       "1  Discharge summary      Report   NaN      NaN   \n",
       "2  Discharge summary      Report   NaN      NaN   \n",
       "3  Discharge summary      Report   NaN      NaN   \n",
       "4  Discharge summary      Report   NaN      NaN   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  TEXT  \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Admission Date:  [**2151-7-16**]       Discharge Date:  [**2151-8-4**]\\n\\n\\nService:\\nADDENDUM:\\n\\nRADIOLOGIC STUDIES:  Radiologic studies also included a chest\\nCT, which confirmed cavitary lesions in the left lung apex\\nconsistent with infectious process/tuberculosis.  This also\\nmoderate-sized left pleural effusion.\\n\\nHEAD CT:  Head CT showed no intracranial hemorrhage or mass\\neffect, but old infarction consistent with past medical\\nhistory.\\n\\nABDOMINAL CT:  Abdominal CT showed lesions of\\nT10 and sacrum most likely secondary to osteoporosis. These can\\nbe followed by repeat imaging as an outpatient.\\n\\n\\n\\n                            [**First Name8 (NamePattern2) **] [**First Name4 (NamePattern1) 1775**] [**Last Name (NamePattern1) **], M.D.  [**MD Number(1) 1776**]\\n\\nDictated By:[**Hospital 1807**]\\nMEDQUIST36\\n\\nD:  [**2151-8-5**]  12:11\\nT:  [**2151-8-5**]  12:21\\nJOB#:  [**Job Number 1808**]\\n  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Admission Date:  [**2118-6-2**]       Discharge Date:  [**2118-6-14**]\\n\\nDate of Birth:                    Sex:  F\\n\\nService:  MICU and then to [**Doctor Last Name **] Medicine\\n\\nHISTORY OF PRESENT ILLNESS:  This is an 81-year-old female\\nwith a history of emphysema (not on home O2), who presents\\nwith three days of shortness of breath thought by her primary\\ncare doctor to be a COPD flare.  Two days prior to admission,\\nshe was started on a prednisone taper and one day prior to\\nadmission she required oxygen at home in order to maintain\\noxygen saturation greater than 90%.  She has also been on\\nlevofloxacin and nebulizers, and was not getting better, and\\npresented to the [**Hospital1 18**] Emergency Room.\\n\\nIn the [**Hospital3 **] Emergency Room, her oxygen saturation was\\n100% on CPAP.  She was not able to be weaned off of this\\ndespite nebulizer treatment and Solu-Medrol 125 mg IV x2.\\n\\nReview of systems is negative for the following:  Fevers,\\nchills, nausea, vomiting, night sweats, change in weight,\\ngastrointestinal complaints, neurologic changes, rashes,\\npalpitations, orthopnea.  Is positive for the following:\\nChest pressure occasionally with shortness of breath with\\nexertion, some shortness of breath that is positionally\\nrelated, but is improved with nebulizer treatment.\\n\\nPAST MEDICAL HISTORY:\\n1. COPD.  Last pulmonary function tests in [**2117-11-3**]\\ndemonstrated a FVC of 52% of predicted, a FEV1 of 54% of\\npredicted, a MMF of 23% of predicted, and a FEV1:FVC ratio of\\n67% of predicted, that does not improve with bronchodilator\\ntreatment.  The FVC, however, does significantly improve with\\nbronchodilator treatment consistent with her known reversible\\nair flow obstruction in addition to an underlying restrictive\\nventilatory defect.  The patient has never been on home\\noxygen prior to this recent episode.  She has never been on\\nsteroid taper or been intubated in the past.\\n2. Lacunar CVA.  MRI of the head in [**2114-11-4**]\\ndemonstrates \"mild degree of multiple small foci of high T2\\nsignal within the white matter of both cerebral hemispheres\\nas well as the pons, in the latter region predominantly to\\nthe right of midline.  The abnormalities, while nonspecific\\nin etiology, are most likely secondary to chronic\\nmicrovascular infarction.  There is no mass, lesion, shift of\\nthe normal midline strictures or hydrocephalus.  The major\\nvascular flow patterns are preserved.  There is moderate\\nright maxillary, moderate bilateral ethmoid, mild left\\nmaxillary, minimal right sphenoid, and frontal sinus mucosal\\nthickening.  These abnormalities could represent an allergic\\nor some other type of inflammatory process.  Additionally\\nnoted is a moderately enlarged subtotally empty sella\\nturcica\".\\n3. Angina:  Most recent stress test was in [**2118-1-3**]\\ngoing for four minutes with a rate pressure product of\\n10,000, 64% of maximum predicted heart rate without evidence\\nof ischemic EKG changes or symptoms.  The imaging portion of\\nthe study demonstrated no evidence of myocardial ischemia and\\na calculated ejection fraction of 84%.  The patient denies\\nangina at rest and gets angina with walking a few blocks.\\nAre alleviated by sublingual nitroglycerin.\\n4. Hypothyroidism on Synthroid.\\n5. Depression on Lexapro.\\n6. Motor vehicle accident with head injury approximately 10\\nyears ago.\\n\\nMEDICATIONS ON ADMISSION:\\n1. Hydrochlorothiazide 25 q.d.\\n2. Prednisone 60 mg, 50 mg, 40 mg, 20 mg.\\n3. Levofloxacin 500 mg q.d.\\n4. Imdur 60 mg q.d.\\n5. Synthroid 75 mcg q.d.\\n6. Pulmicort nebulizer b.i.d.\\n7. Albuterol nebulizer q.4. prn.\\n8. Lexapro 10 mg q.d.\\n9. Protonix 40 mg q.d.\\n10. Aspirin 81 mg q.d.\\n\\nALLERGIES:  Norvasc leads to lightheadedness and headache.\\n\\nFAMILY HISTORY:  Noncontributory.\\n\\nSOCIAL HISTORY:  Lives with her husband, Dr. [**Known lastname 1809**] an\\neminent Pediatric Neurologist at [**Hospital3 1810**].  The\\npatient is a prior smoker, but has not smoked in over 10\\nyears.  She has no known alcohol use and she is a full code.\\n\\nPHYSICAL EXAM AT TIME OF ADMISSION:  Blood pressure 142/76,\\nheart rate 100 and regular, respirations at 17-21, and 97%\\naxillary temperature.  She was saturating at 100% on CPAP\\nwith dry mucous membranes.  An elderly female in no apparent\\ndistress.  Pupils are equal, round, and reactive to light and\\naccommodation.  Extraocular movements are intact.  Oropharynx\\ndifficult to assess due to CPAP machine.  No evidence of\\njugular venous pressure, however, the strap from the CPAP\\nmachine obscures the neck exam.  Cranial nerves II through\\nXII are grossly intact.  Neck is supple without\\nlymphadenopathy.  Heart exam:  Tachycardic, regular, obscured\\nby loud bilateral wheezing with increase in the expiratory\\nphase as well as profuse scattered rhonchi throughout the\\nlung fields.  Positive bowel sounds, soft, nontender,\\nnondistended, obese, no masses.  Mild edema of the lower\\nextremities without clubbing or cyanosis, no rashes.  There\\nis a right hand hematoma.  Strength is assessed as [**5-9**] in the\\nlower extremities, [**5-9**] in the upper extremities with a normal\\nmental status and cognition.\\n\\nLABORATORY STUDIES:  White count 19, hematocrit 41, platelets\\n300.  Chem-7:  127, 3.6, 88, 29, 17, 0.6, 143.  Troponin was\\nnegative.  CKs were negative times three.  Initial blood gas\\nshowed a pH of 7.4, pO2 of 66, pCO2 of 54.\\n\\nChest x-ray demonstrates a moderate sized hiatal hernia,\\nsegmental atelectasis, left lower lobe infiltrate versus\\nsegmental atelectasis.\\n\\nEKG shows normal sinus rhythm at 113 beats per minute, normal\\naxis, no evidence of ST-T wave changes.\\n\\nBRIEF SUMMARY OF HOSPITAL COURSE:\\n1. COPD/dyspnea/pneumonia:  The patient was initially placed\\non an aggressive steroid taper and admitted to the Medical\\nIntensive Care Unit due to her difficulty with oxygenation\\ndespite CPAP machine.  She was also given nebulizer\\ntreatments q.4h. as well as chest PT.  The nebulizers were\\nincreased to q.1h. due to the fact that she continued to have\\nlabored breathing.\\n\\nDue to persistent respiratory failure and labored breathing,\\nthe patient was intubated on [**2118-6-7**] in order to improve\\noxygenation, ventilation, and ability to suction.  A\\nbronchoscopy was performed on [**2118-6-7**], which demonstrated\\nmarked narrowing of the airways with expiration consistent\\nwith tracheomalacia.\\n\\nOn [**2118-6-9**], two silicone stents were placed, one in the left\\nmain stem (12 x 25 and one in the trachea 16 x 40) by Dr.\\n[**First Name (STitle) **] [**Name (STitle) **] under rigid bronchoscopy with general anesthesia.\\n\\nOn [**2118-6-11**], the patient was extubated to a cool mist shovel\\nmask and her oxygen was titrated down to 2 liters nasal\\ncannula at which time she was transferred to the medical\\nfloor.  On the medical floor, the steroids were weaned to off\\non [**2118-6-14**], and the patient was saturating at 97% on 2\\nliters, 92% on room air.\\n\\nOn [**2118-6-14**], the patient was seen again by the Interventional\\nPulmonology service, who agreed that she looked much improved\\nand recommended that she go to pulmonary rehabilitation with\\nfollowup within six weeks' time status post placement of\\nstents in respiratory failure.\\n\\n2. Cardiovascular:  The patient was ruled out for a MI.  She\\ndid have another episode on the medical floor of chest pain,\\nwhich showed no evidence of EKG changes and negative\\ntroponin, negative CKs x3.  She was continued on aspirin,\\nImdur, and diltiazem for rate control per her outpatient\\nregimen.\\n\\n3. Hypertension:  She was maintained on diltiazem and\\nhydrochlorothiazide with adequate blood pressure control and\\nnormalization of electrolytes.\\n\\n4. Hematuria:  The patient had intermittent hematuria likely\\nsecondary to Foley placement.  The Foley catheter was\\ndiscontinued on [**2118-6-14**].  She had serial urinalyses, which\\nwere all negative for signs of infection.\\n\\n5. Hyperglycemia:  Patient was placed on insulin-sliding\\nscale due to hyperglycemia, which was steroid induced.  This\\nworked quite well and her glucose came back to normal levels\\nonce the steroids were tapered to off.\\n\\n6. Leukocytosis:  Patient did have a profound leukocytosis of\\n20 to 22 during much of her hospital course.  As the steroids\\nwere tapered to off, her white blood cell count on [**2118-6-14**]\\nwas 15,000.  It was felt that the leukocytosis was secondary\\nto both steroids as well as question of a left lower lobe\\npneumonia.\\n\\n7. For the left lower lobe pneumonia, the patient had\\ninitially received a course of levofloxacin 500 p.o. q.d.\\nfrom [**2118-6-4**] to [**2118-6-10**].  This was restarted on [**2118-6-12**]\\nfor an additional seven day course given the fact that she\\nstill had the leukocytosis and still had marked rales at the\\nleft lower lobe.\\n\\n8. Hypothyroidism:  The patient was continued on outpatient\\nmedical regimen.\\n\\n9. Depression:  The patient was continued on Lexapro per\\noutpatient regimen.  It is recommended that she follow up\\nwith a therapist as an outpatient due to the fact that she\\ndid have a blunted affect throughout much of the hospital\\ncourse, and did appear clinically to be depressed.\\n\\n10. Prophylaxis:  She was maintained on proton-pump inhibitor\\nwith subQ Heparin.\\n\\n11. Sore throat:  The patient did have a sore throat for much\\nof the hospital course post extubation.  This was treated\\nwith Cepacol lozenges as well as KBL liquid (a solution\\ncontaining Kaopectate, Bismuth, and lidocaine) at bedtime.\\n\\n12. Communication/code status:  The patient was full code\\nthroughout her hospital course, and communication was\\nmaintained with the patient and her husband.\\n\\n13. Muscle weakness:  The patient did have profound muscle\\nweakness and was evaluated by Physical Therapy, and was found\\nto have impaired functional mobility, impaired\\nmusculoskeletal performance, impaired gas exchange, impaired\\nendurance, impaired ventilation, and needed help with supine\\nto sit.  However, she was able to tolerate sitting in a chair\\nfor approximately one hour.\\n\\nOn motor exam, her flexors and extensors of the lower\\nextremities were [**4-8**] at the knee, [**4-8**] at the ankle, [**4-8**] at\\nthe elbows, and [**4-8**] hips.  It was felt that this weakness was\\nmost likely due to a combination of steroid myopathy as well\\nas muscle atrophy secondary to deconditioning after a\\nprolonged hospital course.\\n\\n14. Speech/swallow:  The patient had a Speech and Swallow\\nevaluation showing no evidence of dysphagia, no evidence of\\nvocal cord damage status post tracheal stent placement.\\n\\nDISCHARGE CONDITION:  The patient was able to oxygenate on\\nroom air at 93% at the time of discharge.  She was profoundly\\nweak, but was no longer tachycardic and had a normal blood\\npressure.  Her respirations were much improved albeit with\\ntransmitted upper airway sounds.\\n\\nDISCHARGE STATUS:  The patient will be discharged to [**Hospital1 **]\\nfor both pulmonary and physical rehabilitation.\\n\\nDISCHARGE MEDICATIONS:\\n1. Levothyroxine 75 mcg p.o. q.d.\\n2. Citalopram 10 mg p.o. q.d.\\n3. Aspirin 81 mg p.o. q.d.\\n4. Fluticasone 110 mcg two puffs inhaled b.i.d.\\n5. Salmeterol Diskus one inhalation b.i.d.\\n6. Acetaminophen 325-650 mg p.o. q.4-6h. prn.\\n7. Ipratropium bromide MDI two puffs inhaled q.2h. prn.\\n8. Albuterol 1-2 puffs inhaled q.2h. prn.\\n9. Zolpidem tartrate 5 mg p.o. q.h.s. prn.\\n10. Isosorbide dinitrate 10 mg p.o. t.i.d.\\n11. Diltiazem 60 mg p.o. q.i.d.\\n12. Pantoprazole 40 mg p.o. q.24h.\\n13. Trazodone 25 mg p.o. q.h.s. prn.\\n14. SubQ Heparin 5000 units subcutaneous b.i.d. until such\\ntime that the patient is able to get out of bed twice a day.\\n15. Cepacol lozenges q.2h. prn.\\n16. Levofloxacin 500 mg p.o. q.d. for a seven day course to\\nbe completed on [**2118-6-21**].\\n17. Kaopectate/Benadryl/lidocaine 5 mL p.o. b.i.d. prn, not\\nto be given around mealtimes for concern of dysphagia induced\\nby lidocaine.\\n18. Lorazepam 0.5-2 mg IV q.6h. prn.\\n\\nFOLLOW-UP PLANS:  The patient is recommended to followup with\\nDr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1407**], [**Telephone/Fax (1) 1408**] within two weeks of leaving\\nof the hospital.  She is also recommended to followup with\\nthe Interventional Pulmonary service for followup status post\\nstent placement.  She is also recommended to followup with a\\nneurologist if her muscle weakness does not improve within\\none week on physical therapy with concern for steroid-induced\\nmyopathy.\\n\\nFINAL DIAGNOSES:\\n1. Tracheomalacia status post tracheal and left main stem\\nbronchial stent placement.\\n2. Hypertension.\\n3. Hypothyroidism.\\n4. Restrictive lung defect.\\n5. Depression.\\n\\n\\n                     DR.[**Last Name (STitle) **],[**First Name3 (LF) **] 12-207\\n\\n\\nDictated By:[**Last Name (NamePattern1) 1811**]\\nMEDQUIST36\\n\\nD:  [**2118-6-14**]  11:30\\nT:  [**2118-6-14**]  11:33\\nJOB#:  [**Job Number 1812**]\\n  \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Admission Date:  [**2119-5-4**]              Discharge Date:   [**2119-5-25**]\\n\\n\\nService: CARDIOTHORACIC\\n\\nAllergies:\\nAmlodipine\\n\\nAttending:[**Last Name (NamePattern1) 1561**]\\nChief Complaint:\\n81 yo F smoker w/ COPD, severe TBM, s/p tracheobronchoplasty [**5-5**]\\ns/p perc trach [**5-13**]\\n\\nMajor Surgical or Invasive Procedure:\\nbronchoscopy 3/31,4/2,3,[**6-12**], [**5-17**], [**5-19**]\\ns/p trachealplasty [**5-5**]\\npercutaneous tracheostomy [**5-13**] after failed extubation\\ndown size trach on [**5-25**] to size 6 cuffless\\n\\n\\nHistory of Present Illness:\\nThis 81 year old woman has a history of COPD. Over the past five\\n\\nyears she has had progressive difficulties with her breathing.\\nIn\\n[**2118-6-4**] she was admitted to [**Hospital1 18**] for respiratory failure\\ndue\\nto a COPD exacerbation. Due to persistent hypoxemia, she\\nrequired\\nintubation and a eventual bronchoscopy on [**2118-6-9**] revealed marked\\n\\nnarrowing of the airways on expiration consistent with\\ntracheomalacia.\\nShe subsequently underwent placement of two\\nsilicone stents, one in the left main stem and one in the\\ntrachea. During the admission the patient had complaints of\\nchest\\npain and ruled out for an MI. She was subsequently discharged to\\n\\n[**Hospital1 **] for physical and pulmonary rehab. Repeat bronchoscopy\\non\\n[**2118-8-1**] revealed granulation tissue at the distal right lateral\\nwall of the tracheal stent. There was significant malacia of the\\n\\nperipheral and central airways with complete collapse of the\\nairways on coughing and forced expiration. Small nodules were\\nalso noted on the vocal cords. She has noticed improvement in\\nher\\nrespiratory status, but most recently has been in discussion\\nwith Dr. [**First Name4 (NamePattern1) 951**] [**Last Name (NamePattern1) 952**] regarding possible tracheobronchial plasty\\n\\nwith mesh. Tracheal stents d/c [**2119-4-19**] in anticipation of\\nsurgery.\\nIn terms of symptoms, she describes many years of intermittent\\nchest pain that she describes as left sided and occurring at any\\n\\ntime. Currently, she notices it about three times a week, and\\nstates that it seems to resolve after three nitroglycerin.\\nShe currently is dependent on oxygen and wears 1.5-2 liters\\naround the clock. She has frequent coughing and brings up \"dark\\nsputum\".\\n\\n\\n\\nPast Medical History:\\nCOPD flare [**6-7**] s/p intubation, s/p distal tracheal to Left Main\\nStem stents placed [**2118-6-9**]. Stents d/c'd [**2119-4-19**], CAD w/ atypical\\nangina (LAD 30%, RCA 30%, EF 63%), ^chol, hypothyroidism, htn,\\nhiatal hernia, lacunar CVA, s/p ped struck -> head injury & rib\\nfx, depression\\nPMH:\\nCOPD, s/p admit [**6-7**] for exacerbation requiring intubation\\ntracheobronchomalacia, s/p bronchial stenting\\nLarge hiatal hernia\\nLacunar CVA\\nHypothyroidism by records in CCC, although patient denies and is\\n\\nnot taking any medication\\nDepression\\nMVA, s/p head injury approximately 10 years ago\\nHypertension\\nHysterectomy\\n\\n\\nSocial History:\\nSocial History: The patient is married and worked as a clinical\\npsychologist. Her husband is a pediatric neurologist at\\n[**Hospital3 **]. They have several children, one of which is\\n\\na nurse.\\n\\n\\nFamily History:\\nFamily History: (+) FHx CAD; Father with an MI in his 40's, died\\n\\nof a CVA at age 59\\n\\n\\nPhysical Exam:\\nAdmit H+P\\nGeneral-lovely 81 yr old feamle in NAD.\\nNeuro- intermittently anxious, MAE, PERRLA, L eye ptosis,\\nsymetrical smile, gossly intact.\\nHEENT-PERRLA, sclera anicteric, pharynx- no exud or erythema\\nResp-clear upper, diffuse ronchi, intermit exp wheezes\\nCor- RRR, No M, R, G\\nAbd- soft, NT, ND, no masses. Slight protrusion at area of\\nhiatal hernia\\nExt- no edema or clubbing\\n\\nBrief Hospital Course:\\n82 y/o female admitted [**2119-5-4**] for consideration of\\ntracheoplasty.\\nBronchoscopy done [**5-4**] confirming severe TBM. Underwent\\ntracheoplasty [**5-5**], complicated by resp failure d/t mucous\\nplugging, hypoxia requiring re-intubation resulting in prolonged\\nICU and hospital course. Also developed right upper extrem DVT\\nfrom mid line.\\n\\nPain- Epidural accidently d/c'd POD#1, pt briefly used dilaudid\\nPCA intermittently w/ fair pain control. Pt required\\nre-intubation for resp failure d/t secretions and PCA d/c at\\nthat time. Propofol for sedation while intubated. Sedation d/c'd\\n[**5-12**] for weaning trial w/ ETT- failed trial. Trach [**5-13**]-weaning\\nefforts as below. Minimal c/o pain since [**5-13**]. Presently pain\\nfree.\\n\\nNeuro- Initially intact- post op aggitation, inhibiting weaning\\nefforts [**5-16**]. Psych eval [**5-18**]-Started on zyprexa and ativan w/\\nimprovement in anxiety. Presently A+Ox3- cooperative and lovely.\\n\\nResp- Extubated POD#2 then required re-intub  [**5-7**] for hypoxia\\nd/t poor cough and mucous plugging. SIMV/PS alt w/CMV at night\\nx4-5d, with CPAP attempts during day.\\nBronchoscopy qd [**Date range (1) 1813**] for secretion management. Bronch [**5-9**]\\nrevealed swollen epiglottis, bronch [**5-10**] - good leak w/ ETT cuff\\ndeflated. Bronch [**5-13**] for eval/trach placement. Last bronch [**5-19**]\\nw/ min secretions present, sputum sent.\\n[**5-13**] perc trach done(#8 Portex- cuffed low pressure maintained to\\npreserve tracheoplasty site). [**5-13**] CPAP15/peep5 initiated post\\ntrach placement. Weaning ongoing.  [**Date range (1) 1814**]- Aggressive weaning\\nw/ increasing episodes of CPAP, progressing to Trach Mask.\\n[**2033-5-20**]-Trach mask overnight w/ no episodes of SOB, or\\nhemodynamic instability. Trach changed to #6 portex- capped and\\n[**Last Name (un) 1815**] well x48hrs on 2LNP. productive cough. Aggressive PT as\\nwell w/ OOB > chair [**Hospital1 **]-tid to total 4-6hr qd. Ambulation\\n~100-120 ft [**5-22**] w/ PT assist.\\n\\nID- Vancomycin started post-op for graft prophylaxis. Fever\\nspike [**2119-5-8**] w/ BAl & sputum sent> + MRSA. Vanco cont to [**4-7**]\\nweeks post trachealplasty. Fever low grade [**5-12**], [**5-15**]> cultured-\\nno new results. [**5-19**]- WBC 20.8 .\\n\\nCardiac-Hypertension controlled w/ hydralazine IV, then d/c and\\ncont controlled. HR 65-75 NSR. Avoiding B Blockers. Lasix 20mg\\nIV qd.\\n[**5-15**]- RUE redness and swelling at site of midline, RUE DVT by\\nultrasound, midline d/c; heparin gtt started and therapeutic\\nrange monitored. [**5-22**]  changed to Lovenox sq [**Hospital1 **]. Coags in good\\ncontrol [**5-23**] (48.2/13.8/1.2)\\nAccess- R midline placed [**2119-5-9**] for access- clotted [**2119-5-15**] and\\nd/c'd.  RUE redness and swelling and DVT via ultrasound. [**5-15**]- L\\nbrachial PICC line placed- TPN resumed.\\n\\nGI-Large hiatal hernia- unable to place enteral feeding tube at\\nbedside or underfluoro. Re-attempt [**5-17**] by EGD doboff tube\\nplaced distal esophagus, dislodged in 12hours and removed.\\n\\nNutrition- PPN/TPN initiated [**2119-5-8**]- [**2119-5-25**]. PICC placed\\n[**2119-5-15**]. Speech and Swallow eval [**5-22**]- rec change trach form #8\\nto #6 Portex to allow improved epiglotis and oropharyngeal\\nmovement to assist w/ swallowing. Then re-eval.  Trach changed\\n[**5-23**] to #6 cuffless portex trach. Passed repeat swallow eval and\\n[**Last Name (un) 1815**] diet of regular solids w/ thin liquids- CHIN TUCK to\\nswallow thin liquids. Give meds whole w/ apple sauce. WOULD\\nRECOMMEND repeat video swallow eval in [**8-17**] days to possibly\\neliminate chin tuck- see page 3 referral.\\n\\nEndo- Hypothyroid, maintained on levoxyl.\\n\\nMuscu/Skel- OOB> chair 4-6hours/day, PT consulting.\\n\\n\\nMedications on Admission:\\nadvair 250/50\", atrovent, imdur 60', lasix 40', lexapro 20',\\nlipitor 10', prilosec 20', mucinex 600\", synthroid 75', detrol\\nLA 4', ambien 5', trazadone 75', melatonin prn\\n\\nDischarge Medications:\\n1. Albuterol Sulfate 0.083 % Solution Sig: One (1)  Inhalation\\nQ6H (every 6 hours) as needed for wheezing.\\n2. Ipratropium Bromide 0.02 % Solution Sig: One (1)  Inhalation\\nQ6H (every 6 hours) as needed for wheezing.\\n3. Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig:\\nOne (1) Disk with Device Inhalation [**Hospital1 **] (2 times a day).\\n4. Albuterol 90 mcg/Actuation Aerosol Sig: 1-2 Puffs Inhalation\\nQ6H (every 6 hours) as needed.\\n5. Ipratropium Bromide 18 mcg/Actuation Aerosol Sig: Two (2)\\nPuff Inhalation QID (4 times a day).\\n6. Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every\\n4 to 6 hours) as needed.\\n7. Sodium Chloride 0.65 % Aerosol, Spray Sig: [**2-5**] Sprays Nasal\\nQID (4 times a day) as needed.\\n8. Camphor-Menthol 0.5-0.5 % Lotion Sig: One (1) Appl Topical\\nTID (3 times a day) as needed.\\n9. Enoxaparin Sodium 60 mg/0.6mL Syringe Sig: One (1)\\nSubcutaneous Q12H (every 12 hours).\\n10. Trazodone HCl 50 mg Tablet Sig: 1.5 Tablets PO HS (at\\nbedtime) as needed.\\n11. Escitalopram Oxalate 10 mg Tablet Sig: Two (2) Tablet PO\\nDAILY (Daily).\\n12. Nystatin 100,000 unit/g Cream Sig: One (1) Appl Topical  [**Hospital1 **]\\n(2 times a day).\\n13. Pantoprazole Sodium 40 mg Tablet, Delayed Release (E.C.)\\nSig: One (1) Tablet, Delayed Release (E.C.) PO Q24H (every 24\\nhours).\\n14. Tolterodine Tartrate 2 mg Tablet Sig: One (1) Tablet PO BID\\n(2 times a day).\\n15. Levothyroxine Sodium 75 mcg Tablet Sig: One (1) Tablet PO\\nDAILY (Daily).\\n16. Heparin Lock Flush (Porcine) 100 unit/mL Syringe Sig: One\\n(1) ML Intravenous  DAILY (Daily) as needed.\\n\\n\\nDischarge Disposition:\\nExtended Care\\n\\nFacility:\\n[**Hospital3 7**] & Rehab Center - [**Hospital1 8**]\\n\\nDischarge Diagnosis:\\nCOPD, Coronary Artery Disease/atypical angina (LAD 30%, RCA 30%,\\nEF 63%), hypercholesterolemia, hypothyroidism, Hypertension,\\nhiatal hernia, Cerebral Vascular Accident,s/p Motor Vehicle\\nColision-> head injury & rib fracture.\\nTBM- s/p tracheoplasty.\\n\\n\\nDischarge Condition:\\ngood\\n\\nDischarge Instructions:\\nplease update Dr.[**Name (NI) 1816**] [**Telephone/Fax (1) 170**] office for:  fever,\\nshortness of breath, chest pain , productive cough or if you\\nhave any questions or concerns.\\n\\n\\nCompleted by:[**2119-5-25**]  \n",
       "3  Admission Date:  [**2124-7-21**]              Discharge Date:   [**2124-8-18**]\\n\\n\\nService: MEDICINE\\n\\nAllergies:\\nAmlodipine\\n\\nAttending:[**First Name3 (LF) 898**]\\nChief Complaint:\\nCOPD exacerbation/Shortness of Breath\\n\\nMajor Surgical or Invasive Procedure:\\nIntubation\\narterial line placement\\nPICC line placement\\nEsophagogastroduodenoscopy\\n\\n\\nHistory of Present Illness:\\n87 yo F with h/o CHF, COPD on 5 L oxygen at baseline,\\ntracheobronchomalacia s/p stent, presents with acute dyspnea\\nover several days, and lethargy. This morning patient developed\\nan acute worsening in dyspnea, and called EMS. EMS found patient\\ntachypnic at saturating 90% on 5L. Patient was noted to be\\ntripoding. She was given a nebulizer and brought to the ER.\\n.\\nAccording the patient's husband, she was experiencing symptoms\\nconsistent with prior COPD flares. Apparently patient was\\nwithout cough, chest pain, fevers, chills, orthopnea, PND,\\ndysuria, diarrhea, confusion and neck pain. Her husband is a\\nphysician and gave her a dose of levaquin this morning.\\n.\\nIn the ED, patient was saturating 96% on NRB. CXR did not reveal\\nany consolidation. Per report EKG was unremarkable. Laboratory\\nevaluation revealed a leukocytosis if 14 and lactate of 2.2.\\nPatient received combivent nebs, solumedrol 125 mg IV x1,\\naspirin 325 mg po x1. Mg sulfate 2 g IV x1, azithromycin 500 mg\\nIVx1, levofloxacin 750 mg IVx1, and Cefrtiaxone 1g IVx1. Patient\\nbecame tachpnic so was trialed on non-invasive ventilation but\\nbecame hypotensive to systolics of 80, so noninvasive was\\nremoved and patient did well on NRB and nebulizers for about 2\\nhours. At that time patient became agitated, hypoxic to 87% and\\ntachypnic to the 40s, so patient was intubated. Post intubation\\nABG was 7.3/60/88/31. Propafol was switched to\\nfentanyl/midazolam for hypotension to the 80s. Received 2L of\\nNS. On transfer, patient VS were 102, 87/33, 100% on 60% 450 x\\n18 PEEP 5. Patient has peripheral access x2.\\n.\\nIn the ICU, patient appeared comfortable.\\n\\nReview of sytems:\\nlimited due to patient sedation\\n\\n\\nPast Medical History:\\n# COPD flare FEV1 40% in [**2120**], on 5L oxygen, s/p intubation\\n[**6-6**], s/p distal tracheal to Left Main Stem stents placed\\n[**2118-6-9**]. Stents d/c'd [**2119-4-19**]. Tracheobronchoplasty performed [**6-6**], [**2119**]\\n# CAD w/ atypical angina (cath [**2119**] - LAD 30%, RCA 30%, EF 63%)\\n# Dyslipidemia\\n# Hypothyroidism,\\n# Hypertension\\n# Hiatal hernia,\\n# lacunar CVA,\\n# s/p ped struck -> head injury & rib fx,\\n# depression\\n\\nSocial History:\\nThe patient is married and worked as a clinical\\npsychologist. Her husband is a pediatric neurologist at\\n[**Hospital3 **]. They have several children, one of which is\\na nurse. [**First Name (Titles) 1817**] [**Last Name (Titles) 1818**] with 40 pack years, quit 5 years ago.\\nSocial ethanol user. No history of IVDU, but remote history of\\nmarijuana use.\\n\\nFamily History:\\n(+) FHx CAD; Father with an MI in his 40's, died\\nof a CVA at age 59\\n\\nPhysical Exam:\\nOn admission\\nVitals: T: BP: 116/46 P: 92 O2: 100%\\nTV 60% 450 x 18 PEEP 5\\nGeneral: Intubated, sedated, no apparent discomfort\\nHEENT: Sclera anicteric, MMM, oropharynx clear\\nNeck: supple, JVP not elevated, no LAD\\nLungs: crackles bases bilaterally\\nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs,\\ngallops\\nAbdomen: soft, non-tender, non-distended, bowel sounds present,\\nno rebound tenderness or guarding, no organomegaly\\nGU: no foley\\nExt: warm, well perfused, 2+ pulses, no clubbing, cyanosis or\\nedema\\n\\n\\nPertinent Results:\\nInitial Labs\\n[**2124-7-21**] 10:55AM BLOOD WBC-14.1*# RBC-4.20# Hgb-12.6# Hct-39.1#\\nMCV-93 MCH-30.1 MCHC-32.3 RDW-12.6 Plt Ct-319\\n[**2124-7-21**] 10:55AM BLOOD Neuts-93.9* Lymphs-4.4* Monos-1.3*\\nEos-0.2 Baso-0.2\\n[**2124-7-22**] 03:50AM BLOOD PT-11.0 PTT-28.7 INR(PT)-0.9\\n[**2124-7-21**] 10:55AM BLOOD Glucose-168* UreaN-13 Creat-0.8 Na-140\\nK-3.5 Cl-92* HCO3-36* AnGap-16\\n[**2124-7-22**] 03:50AM BLOOD Calcium-8.8 Phos-3.4 Mg-2.1\\n\\nCardiac Biomarkers\\n[**2124-7-21**] 10:55AM BLOOD CK(CPK)-321* cTropnT-0.02*\\n[**2124-7-21**] 06:25PM BLOOD CK(CPK)-345* CK-MB-14* MB Indx-4.1\\ncTropnT-0.01\\n[**2124-7-22**] 03:50AM BLOOD CK(CPK)-845* CK-MB-15* MB Indx-1.8\\ncTropnT-0.01\\n[**2124-7-22**] 12:04PM BLOOD CK(CPK)-1030* CK-MB-15* MB Indx-1.5\\ncTropnT-0.01\\n[**2124-7-23**] 03:15AM BLOOD CK(CPK)-530* CK-MB-9 cTropnT-0.01\\nproBNP-2535*\\n\\nCXR ([**2124-7-21**]) - IMPRESSION: Hiatal hernia, otherwise\\nunremarkable. Limited exam.\\n\\nEcho ([**2124-7-24**]) - There is mild symmetric left ventricular\\nhypertrophy with normal cavity size and regional/global systolic\\nfunction (LVEF>55%). The estimated cardiac index is normal\\n(>=2.5L/min/m2). Tissue Doppler imaging suggests an increased\\nleft ventricular filling pressure (PCWP>18mmHg). Right\\nventricular chamber size is normal. with normal free wall\\ncontractility. The aortic valve leaflets (3) are mildly\\nthickened but aortic stenosis is not present. No aortic\\nregurgitation is seen. The mitral valve leaflets are mildly\\nthickened. There is no mitral valve prolapse. Mild (1+) mitral\\nregurgitation is seen. The tricuspid valve leaflets are mildly\\nthickened. There is moderate pulmonary artery systolic\\nhypertension. There is an anterior space which most likely\\nrepresents a prominent fat pad.\\nIMPRESSION: Normal biventricular systolic function. Moderate\\npulmonary artery systolic hypertension.\\n\\nCXR ([**2124-8-5**]) - Kyphotic positioning. Compared with one day\\nearlier and allowing for technical differences, the right-sided\\neffusion may be slightly larger. Otherwise, no significant\\nchange is detected. Again seen is retrocardiac opacity\\nconsistent with left lower lobe collapse and/or consolidation\\nand a small left effusion. As noted, a right effusion is again\\nseen, possibly slightly larger on the current examination, with\\nunderlying collapse and/or consolidation. Doubt CHF.\\nDegenerative changes of the thoracic spine are noted.\\n\\nCardiac Enzymes [**2124-8-12**]: Trop<0.01\\n                [**2124-8-13**]: Trop 0.03\\n                [**2124-8-14**]: Trop 0.02\\n\\nLABS AT DISCHARGE:\\n\\n[**2124-8-16**] 05:40AM BLOOD WBC-9.5 RBC-3.08* Hgb-9.6* Hct-28.3*\\nMCV-92 MCH-31.2 MCHC-33.9 RDW-13.5 Plt Ct-360\\n[**2124-8-16**] 05:40AM BLOOD PT-10.4 PTT-22.8 INR(PT)-0.8*\\n[**2124-8-17**] 05:30AM BLOOD Glucose-114* UreaN-18 Creat-0.8 Na-142\\nK-3.5 Cl-101 HCO3-36* AnGap-9\\n[**2124-8-16**] 05:40AM BLOOD Calcium-8.9 Phos-2.8 Mg-2.3\\n[**2124-8-16**] 05:40AM BLOOD TSH-0.87\\n\\nBrief Hospital Course:\\n87 yo F with h/o CHF, COPD on 5 L oxygen at baseline,\\ntracheobronchomalacia s/p stent, presents with acute dyspnea\\nover several days, no s/p intubation for hypercarbic respiratory\\nfailure.\\n\\n# Hypercarbic respiratory failure: Presents with dyspnea, but no\\nclear cough or fevers. Per report, patient felt like this with\\nprior COPD exacerbations. Leukocytosis supports possible\\npneumonia, but history and CXR not entirely consistent with\\nthis. EKG with signs of demand, but ROMI negative. Sputum gram\\nstain unremarkable, but respitatory viral culture grew\\nparainfluenze type 3 on [**7-24**]. Patient was initially managed on\\nsolumedrol 60 mg IV Q8H, and was eventually tapered. With no\\nevidence of pneumonia on CXR and sputum gram stain, antibiotics\\nwere stopped [**7-25**]. Beta-agonists and anticholinergics were\\ncontinued around the clock. TTE revealed mild symmetric lvh with\\nnormal ef, increased pcwp (>18mmHg), Normal RV, and moderate\\npulmonary artery systolic hypertension. On [**7-26**], bronchoscopy\\nrevealed collapsible, unremarkable airways. Patient had\\ndifficulty weaning from the vent, and would become\\ninterimittenty hypertensive to SBP 200s and tachypnic to the\\n50s. Patient was extubatied on [**7-27**] after passing SBT 0/5, but\\nrequired re-intubation 30 minutes later for worsening\\nsecretions, lack of gag reflex, and tachypnea to the 50s. Of\\nnote, on [**8-1**], the patient was found to have MRSA growing in\\nsputum samples. Although it was felt that this likely\\nrepresented colonization as opposed to true infection, the\\npatient was started on a course of vancomycin (which was stopped\\nafter 5 days). After multiple discussions between the patient's\\nfamily and the ICU team, the patient's PCP, [**Name10 (NameIs) **] the palliative\\ncare service, the patient's family ultimately decided that she\\nwould not want a tracheostomy. On [**2124-8-3**], extubation was pursued\\nagain and was successful. After extubation, her respiratory\\nstatus improved and she was ultimately called out to the medical\\nfloor. On the floor she was progressively weaned to 2LNC with\\nnebs (better than her baseline 5L @home). Because of clinical\\nexams revealing mild volume overload, she was intermittently\\ndiuresed. She also experienced intermittent shortness of breath\\nwith tachypnea but this was thought to be the result of attacks\\nof anxiety with tachypnea. After receiving prn morphine, her\\nbreathing status would typically improve. A steroid taper was\\nbegun. The patient should continue prednisone 30 mg daily for 3\\nmore days, then 20 mg daily for 4 days, then 10 mg daily for 4\\ndays, then 5 mg daily for 4 days, then stop.\\n.\\n# Upper GI bleeding: On [**7-22**], patient had coffee grounds from OG\\ntube. Lavage for approx 600ccs with clearance. GI perfomred EGD\\nwhich revealed esophagitis, ulcers and blood in the stomach\\nbody, D2 diverticulum and large hiatal hernia. H pylori was\\nnegative. Patient was continued on IV PPI, with plan for repeat\\nEGD in 8 weeks, and upper GI series once clinically improved\\ngiven abnormal anatomy on EGD. Her hematocrit remained stable\\nwith no further episodes of upper GI bleeding throughout the\\npatient's hospitalization. On the floor she was switched to PO\\npantoprazole twice daily. Aspirin was held.\\n.\\n# Weakness: The patient was found to have generalized weakness\\nat the end of her hospitalization. Neurology was consulted and\\nthey felt it was likely due to a combination of steroid myopathy\\nand deconditioning from her prolonged bedbound status. A TSH was\\nchecked which was normal. They recommended pulmonary and\\nphysical rehab.\\n.\\n# CAD: History of LAD and RCA stenosis on Cath, but no stents.\\nContinued statin and beta blocker, but held aspirin for GI\\nbleeding (see above)\\n.\\n# Nutrition: Unable to pass NG without direct visualization due\\nto hiatal hernia. IR guided post pyloric NG tube was placed on\\n[**7-26**] for TFs and po medications. NG tube was pulled when patient\\nwas extubated on [**2124-8-3**]. Speech and swallow were consulted\\nfollowing the patient's extubation and she was eventually moved\\nto soft solids and thin liquids with 1:1 supervision.\\n\\n# Goals of care: PCP [**Last Name (NamePattern4) **]. [**Last Name (STitle) 1407**] was very involved in discussions\\nregarding patient's code status. Palliative care also followed\\nalong with the patient. Ultimately, at the time of the patient's\\nextubation on [**2124-8-3**], it was decided that the patient would be\\nDNR/DNI (although this was later change). The patient's family\\nfelt that she would not want a tracheostomy. It was decided that\\nshe would not be reintubated and that, if her respiratory status\\nwere to worsen after intubation, care would be focused on\\ncomfort. However, her status improved in the MICU and on the\\nfloor and it was then decided that she would remain DNR with\\nintubation (but no tracheostomy) if her breathing deteriorated.\\nAfter several days with stable or improved overall clinical\\nstatus, she was deemed suitable for rehabilitation. At the timem\\nof discharge, the patient's code status was do not resuscitate,\\nokay to intubate.\\n\\nMedications on Admission:\\n# Omeprazole 20 mg daily\\n# Furosemide 20 mg daily\\n# Toprol XL 50 mg daily\\n# Lipitor 20 mg daily\\n# Folic Acid 1 mg daily\\n# Centrum daily\\n# Diovan 80 mg daily\\n# Trazodone 75-100 mg qhs\\n# Melatonin 3 mg qhs\\n# [**Doctor Last Name 1819**] Aspirin 325 mg daily\\n# Albuterol neb prn\\n# Duoneb prn\\n# Advair 250/50 [**Hospital1 **]\\n# Zolpidem 2.5 mg qhs prn\\n# Synthroid 100 mcg daily\\n# Lexapro 20 mg daily\\n\\n\\nDischarge Medications:\\n1. Metoprolol Succinate 50 mg Tablet Sustained Release 24 hr\\nSig: One (1) Tablet Sustained Release 24 hr PO once a day.\\n2. Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY\\n(Daily).\\n3. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).\\n\\n4. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily).\\n\\n5. Trazodone 50 mg Tablet Sig: One (1) Tablet PO at bedtime as\\nneeded for insomnia.\\n6. Melatonin 3 mg Tablet Sig: One (1) Tablet PO at bedtime.\\n7. Valsartan 160 mg Tablet Sig: 1.5 Tablets PO once a day.\\n8. Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for\\nNebulization Sig: One (1) neb Inhalation every 4-6 hours as\\nneeded for shortness of breath or wheezing.\\n9. DuoNeb 0.5 mg-3 mg(2.5 mg base)/3 mL Solution for\\nNebulization Sig: One (1) neb Inhalation every six (6) hours as\\nneeded for shortness of breath or wheezing.\\n10. Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig:\\nOne (1) puff Inhalation twice a day.\\n11. Escitalopram 10 mg Tablet Sig: Two (2) Tablet PO DAILY\\n(Daily).\\n12. Levothyroxine 100 mcg Tablet Sig: One (1) Tablet PO DAILY\\n(Daily).\\n13. Prednisone 20 mg Tablet Sig: One (1) Tablet PO daily () for\\n4 days: Start after 3 days of 30 mg daily.\\n14. Prednisone 10 mg Tablet Sig: One (1) Tablet PO daily () for\\n4 days: Start after 4 days of 20 mg daily.\\n15. Prednisone 5 mg Tablet Sig: One (1) Tablet PO daily () for 4\\ndays: Start after 4 days of 10 mg daily.\\n16. Hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO\\nDAILY (Daily).\\n17. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One\\n(1) Tablet, Delayed Release (E.C.) PO twice a day.\\n18. Morphine 10 mg/5 mL Solution Sig: Five (5) mg PO every four\\n(4) hours as needed for respiratory discomfort: Hold for\\noversedation or RR<12.\\n19. Prednisone 10 mg Tablet Sig: Three (3) Tablet PO once a day\\nfor 3 days.\\n20. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day.\\n21. Senna 8.6 mg Tablet Sig: One (1) Tablet PO twice a day as\\nneeded for constipation.\\n22. Humalog insulin sliding scale\\nPlease use attached Humalog insulin sliding scale while on\\nsteroids.\\n\\n\\nDischarge Disposition:\\nExtended Care\\n\\nFacility:\\n[**Location 1820**] center at [**Location (un) 1821**]\\n\\nDischarge Diagnosis:\\nPrimary:\\n1. Chronic Obstructive Pulmonary Disease Exacerbation\\n2. Respiratory failure with intubation\\n3. Upper gastrointestinal bleed/Peptic Ulcer Disease\\n4. Hypertension\\n5. Anxiety\\n\\nSecondary:\\n1. Coronary Artery Disease\\n2. Hypothyroidism\\n\\n\\nDischarge Condition:\\nMental Status: Confused - sometimes.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Out of Bed with assistance to chair or\\nwheelchair.\\n\\n\\nDischarge Instructions:\\nYou were admitted to the hospital with shortness of breath and\\nrespiratory failure and lethargy. In the emergency department,\\nyou were breathing very fast and a breathing tube was inserted\\ninto your airway to help you breathe. You were admitted to the\\nintensive care unit. There, you were managed with steroids and\\nantibiotics and the tube was eventually removed from your\\nairway, allowing you to breathe on your own. You also underwent\\nbronchoscopy which looked at the inside of your airways.\\n.\\nDuring your time in the intensive care unit, you developed a\\ngastrointestinal bleed. A tube was placed into your stomach and\\nyou underwent an endoscopic procedure to look at your esophagus\\nand stomach. This showed inflammation in your esophagusand\\nulcers in your stomach.\\n.\\nYou should continue to use nasal oxygen by nasal cannula as\\nneeded. You should continue the steroid taper as instructed. You\\nshould call your doctor or return to the emergency room if you\\nhave increasing difficulty breathing or shortness of breath,\\nwheezing, chest pain, blood in your stool or vomiting blood.\\n.\\nThere are some changes in your medications.\\nSTART pantoprazole 40 mg twice daily and STOP omeprazole\\nSTART hydrochlorothiazide\\nSTART prednisone, taking 30 mg for 3 days, then 20 mg for 4\\ndays, then 10 mg for 4 days, then 5 mg for 4 days, then stop.\\nSTART colace and senna as needed for constipation\\nCan use morphine to alleviate symptoms of respiratory discomfort\\nSTOP furosemide\\nSTOP zolpidem\\nSTOP aspirin\\nINCREASE Diovan to 240 mg daily\\nDECREASE trazodone to 50 mg daily\\n.\\nFollow up as indicated below.\\n\\nFollowup Instructions:\\nYou have an appointment to follow up with Dr. [**Last Name (STitle) 1407**], your\\nprimary care physician, [**Name10 (NameIs) **] [**8-29**] at 1pm. His address is [**Location (un) 1822**], [**Apartment Address(1) 1823**], [**Location (un) **],[**Numeric Identifier 1700**]. The phone is\\n[**Telephone/Fax (1) 1408**].\\n\\nYou have an appointment to follow up with Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 174**] in\\nthe  [**Hospital **] clinic on [**8-30**] at 3pm in the [**Hospital Unit Name 1824**] at [**Hospital1 18**] on the [**Location (un) 453**]. Their phone number is\\n[**Telephone/Fax (1) 463**].\\n\\nDepartment: DIV. OF GASTROENTEROLOGY\\nWhen: WEDNESDAY [**2124-8-30**] at 3:00 PM\\nWith: [**First Name4 (NamePattern1) 1386**] [**Last Name (NamePattern1) **], MD [**Telephone/Fax (1) 463**]\\nBuilding: Ra [**Hospital Unit Name 1825**] ([**Hospital Ward Name 1826**]/[**Hospital Ward Name 1827**] Complex) [**Location (un) **]\\nCampus: EAST     Best Parking: Main Garage\\n\\n\\n\\n  \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Admission Date:  [**2162-3-3**]              Discharge Date:   [**2162-3-25**]\\n\\nDate of Birth:  [**2080-1-4**]             Sex:   M\\n\\nService: MEDICINE\\n\\nAllergies:\\nPatient recorded as having No Known Allergies to Drugs\\n\\nAttending:[**First Name3 (LF) 1828**]\\nChief Complaint:\\nMr. [**Known lastname 1829**] was seen at [**Hospital1 18**] after a mechanical fall from\\na height of 10 feet.  CT scan noted unstable fracture of C6-7 &\\nposterior elements.\\n\\nMajor Surgical or Invasive Procedure:\\n1. Anterior cervical osteotomy, C6-C7, with decompression and\\nexcision of ossification of the posterior longitudinal ligament.\\n2. Anterior cervical deformity correction.\\n3. Interbody reconstruction.\\n4. Anterior cervical fusion, C5-C6-C7.\\n5. Plate instrumentation, C5-C6-C7.\\n6. Cervical laminectomy C6-C7, T1.\\n7. Posterior cervical arthrodesis C4-T1.\\n8. Cervical instrumentation C4-T1.\\n9. Arthrodesis augmentation with autograft, allograft and\\ndemineralized bone matrix.\\n\\n\\nHistory of Present Illness:\\nMr. [**Known lastname 1829**] is a 82 year old male who had a slip and fall\\nof approximately 10 feet from a balcony.  He was ambulatory at\\nthe scene.  He presented to the ED here at [**Hospital1 18**].  CT scan\\nrevealed unstable C spine fracture.  He was intubated secondary\\nto agitation.\\n\\nPatient admitted to trauma surgery service\\n\\nPast Medical History:\\nCoronary artery disease s/p CABG\\nCHF\\nHTN\\nAICD\\nAtrial fibrillation\\nStroke\\n\\nSocial History:\\nPatient recently discharged from [**Hospital1 **] for severe\\ndepression. Family reports patient was very sad and attempted to\\nkill himself by wrapping a telephone cord around his neck. Lives\\nwith his elderly wife, worked as a chemist in [**Country 532**].\\n\\nFamily History:\\nNon contributory\\n\\nPhysical Exam:\\nPhycial exam prior to surgery was not obtained since patient was\\nintubated and sedated.\\n\\nPost surgical physical exam: (TSICU per surgery team)\\n\\nBreathing without assistance\\nNAD\\nVitals: T 97.5, HR 61, BP 145/67, RR22, SaO2 98\\nA-fib, rate controlled\\nAbd soft non-tender\\nAnterior/Posterior cervical incisions [**Name (NI) 1830**]\\nPt is edemitous in all four extremities, no facial edema\\nAble to grossly move all four extremities, neurointact to light\\ntouch\\nDistal pulses weakly intact\\n\\nMedicine Consult:\\nVS: Tm/c 98.9 142/70 61 20 96%RA\\nI/O BM yesterday 220/770\\nGen: awake, calm, cooperative and pleasant, lying in bed\\nNeck: c-collar removed\\nCV: irregular, normal S1, S2. No m/r/g.\\nlungs: cta anteriolry\\nAbd: Obese, Soft, NTND, decreased bs\\nExt: trace b/l le edema, 1+ UE edema\\nneuro/cognition: thought [**3-17**], \"8\", not to place,\\n\\n\\nPertinent Results:\\n====================\\n ADMISSION LABS\\n====================\\n\\nWBC-8.4 RBC-4.43* Hgb-11.9* Hct-38.6* MCV-87 MCH-26.9*\\nMCHC-30.9* RDW-17.3* Plt Ct-191\\nPT-20.4* PTT-28.1 INR(PT)-1.9*\\nCK(CPK)-183* Amylase-70\\nCalcium-8.5 Phos-2.0* Mg-1.9\\nGlucose-121* Lactate-2.3* Na-140 K-4.3 Cl-101 calHCO3-26\\n\\n==================\\n   RADIOLOGY\\n==================\\n\\nCT scan C spine [**2162-3-3**]:\\nIMPRESSION:\\n1.  Fracture of the C6 as described involving the right pedicle\\n(extending to the inferior facet) and left lamina. Anterior\\nwidening at the C6-7 disc space and mild widening of left C6-7\\nfacet also noted. Prevertebral hematoma at C6 with likely\\nrupture of the anterior longitudinal ligament.\\n\\n2.  Lucency in the right posterior C1 ring may represent a\\nchronic injury.\\nLikely old avulsion fracture at T2 pedicle on the left.\\n\\n3. Ossification of both anterior and posterior longitudinal\\nligaments with\\ncompromise of the central spinal canal. Degenerative disease is\\nfurther\\ndescribed above.\\n\\nCT ABDOMEN/PELVIS ([**2162-3-3**])\\nIMPRESSION:\\n1. No acute injuries in the chest, abdomen, or pelvis.\\n2. Three discrete pleural fluid collections in the right\\nhemithorax, likely pseudotumors.\\n3. Small hypodense lesion in the pancreatic body is of unclear\\netiology, may represent pseudicyst or cystic tumor. Further\\nevaluation with MRI may be performed on a non- emergent basis.\\n4. Bilateral renal cysts.\\n5. Foley catheter balloon inflated within the prostatic urethra.\\nRecommend emergent repositioning.\\n\\nCT SINUS/MAXILLOFACIAL ([**2162-3-3**])\\n1. Bilateral nasal bone fractures.\\n2. Left frontal scalp hematoma with preseptal soft tissue\\nswelling. Question foreign body anterior to the left globe.\\nRecommend clinical correlation. Small amount of extraconal\\nhematoma in the superior aspect of the left orbit.\\n3. Linear lucency in the right posterior ring of C1. Correlate\\nwith CT C- spine performed concurrently.\\n\\nHEAD CT ([**2162-3-3**])\\n1. No acute intracranial hemprrhage.\\n2. Left frontal scalp hematoma.\\n3. Nasal bone fractures. Recommend correlation with report from\\nfacial bone CT scan.\\n4. Lucency in the right posterior ring of C1. Please refer to\\ndedeicated CT C-spine for further detail.\\n5. Left cerebellar encephalomalacia, likely due to old\\ninfarction.\\n\\nCHEST [**2162-3-10**]\\nThe Dobbhoff tube passes below the diaphragm with its tip most\\nlikely terminating in the stomach. The bilateral pacemakers are\\ndemonstrated with one lead terminating in right atrium and three\\nleads terminating in right ventricle. The patient is in mild\\npulmonary edema with no change in the loculated pleural fluid\\nwithin the major fissure.\\n\\nCT HEAD [**2162-3-11**]\\n1. A tiny amount of intraventricular hemorrhage layers along the\\noccipital horns of the ventricles bilaterally. Recommend followp\\nimaging.\\n2. Left frontal scalp hematoma has decreased in size.\\n3. Unchanged left cerebellar encephalomalacia.\\n4. Nasal bone fractures are better evaluated on dedicated\\nmaxillofacial CT.\\n\\nRIGHT SHOULDER X-RAY ([**2162-3-11**])\\nMild glenohumeral and acromioclavicular joint osteoarthritis.\\nNonspecific ossification projecting over the upper margin of the\\nscapular body and adjacent to the lesser tuberosity. Diagnostic\\nconsiderations include the sequela of chronic calcific bursitis,\\nintraarticular bodies, and/or calcific tendinitis of the\\nsubscapularis tendon.\\nIncreased opacity projecting over the right hemithorax and minor\\nfissure, better delineated on recent chest radiographs and chest\\nCT\\n\\nRIGHT UPPER EXTREMITY ULTRASOUND ([**2162-3-13**])\\n1. Deep venous thrombosis in the right axillary vein, extending\\nproximally into the right subclavian vein, and distally to\\ninvolve the brachial veins, portion of the basilic vein, and the\\nright cephalic vein.\\n2. Likely 2.0 cm left axillary lymph node, with unusual\\nson[**Name (NI) 493**] features somewhat suspicious for malignancy.\\nFollowup ultrasound is recommended in 4 weeks, and FNA/biopsy\\nmay be considered at that time if no interval improvement.\\n\\n[**2162-3-14**]\\nCT ABDOMEN WITH IV CONTRAST: There are small-to-moderate\\nbilateral pleural effusions, on the right with a loculated\\nappearance. There is associated compressive atelectasis. The\\nvisualized portion of the heart suggests mild cardiomegaly.\\nThere is no pericardial effusion. There is a 9-mm\\nhypoattenuating, well-defined lesion in the left lobe of the\\nliver (2:12) too small to accurately characterize but\\nstatistically most likely representing a cyst. There are\\nbilateral, partially exophytic renal cysts. The spleen is normal\\nin size. There is a 5-mm hypoattenuating focus in the pancreatic\\nbody, most likely representing focal fat. The gallbladder and\\nadrenal glands are unremarkable. An NG tube terminates in the\\nstomach. There is no ascites. The large and small bowel loops\\nappear unremarkable without wall thickening or pneumatosis. Oral\\ncontrast material has passed into the ascending colon without\\nevidence of obstruction. There is no ascites and no free air.\\nThere is a small pocket of air in the left rectus muscle,\\ntracking over a distance of approximately 10 cm.\\n\\nCT PELVIS WITH IV CONTRAST: The pelvic small and large bowel\\nloops, collapsed bladder containing Foley catheter and seminal\\nvesicles appear unremarkable. The prostate is enlarged,\\nmeasuring 5.9 cm in transverse diameter. The rectum contains a\\nmoderate amount of dried stool. There is no free air or free\\nfluid.\\n\\nBONE WINDOWS: No suspicious lytic or sclerotic lesions. There is\\nDISH of the entire visualized thoracolumbar spine. There also\\nare degenerative changes about the hip joints with large\\nacetabular osteophytes.\\n\\nIMPRESSION:\\n1. Stable bilateral pleural effusions, loculated on the right.\\n2. New focus of air tracking within the left rectus muscle with\\nassociated tiny amount of extraperitoneal air (2:53). No\\nassociated stranding or fluid collection. Please correlate\\nclinically if this could be iatrogenic, such as due to s.q.\\ninjections.\\n3. 5-mm hypoattenuating focus in the pancreatic body. This could\\nrepresent focal fat, although a cystic tumor cannot be excluded.\\nIf this is of concern, then MRI is again recommended for further\\nevaluation.\\n4. Hypoattenuating focus in the left lobe of the liver, too\\nsmall to accurately characterize.\\n5. Bilateral partially exophytic renal cysts.\\n6. Moderate amount of dried stool within the rectum.\\n\\nA wet read was placed and the pertinent findings were discussed\\nby Dr. [**First Name (STitle) 1831**] [**Name (STitle) 1832**] with Dr. [**First Name (STitle) 1833**] at 11:30 p.m. on [**2162-3-14**].\\n\\n[**2162-3-16**]\\nVIDEO OROPHARYNGEAL SWALLOW FINDINGS: Real-time video\\nfluoroscopic evaluation was performed after oral administration\\nof thin and puree consistency of barium, in conjunction with the\\nspeech pathologist.\\n\\nORAL PHASE: Normal bolus formation, bolus control, AP tongue\\nmovement, oral transit time, and no oral cavity residue.\\n\\nPHARYNGEAL PHASE: There is normal swallow initiation and velar\\nelevation. There is mild-to-moderate impairment of laryngeal\\nelevation with absent epiglottic deflection. There is\\nmoderate-to-severe increase in pharyngeal transit time. There is\\nresidue in the valleculae and piriform sinuses with moderate\\nimpairment of bolus propulsion. There was aspiration of both\\nthin and puree barium.\\n\\nIMPRESSION: Aspiration of thin liquids and puree. For additional\\ninformation, please see the speech and swallow therapist's\\nreport from the same day.\\n\\n[**2162-3-18**] CT Head w/out:\\nFINDINGS: There is a small amount of blood layering in the\\noccipital horns of both lateral ventricles, unchanged though not\\nas dense given evolution. No new hemorrhage is identified. The\\nventricles, cisterns, and sulci are enlarged secondary to\\ninvolutional change. Periventricular white matter hyperdensities\\nare sequelae of chronic small vessel ischemia. Encephalomalacia\\nin the left cerebellar hemisphere secondary to old infarction is\\nunchanged. The osseous structures are unremarkable. The\\nvisualized paranasal sinuses and mastoid air cells are clear.\\nSkin staples are noted along the superior- posterior neck\\nsecondary to recent spinal surgery.\\n\\nIMPRESSION: No interval change with a very small\\nintraventricular hemorrhage.\\n\\nNo discharge labs as patient CMO.\\n\\nBrief Hospital Course:\\nMr. [**Known lastname 1829**] was seen at [**Hospital1 18**] after his fall from a height\\nof approximatly 10 feet.  CT scans of his chest, abdomen and\\npelvis were negative for pathology.  CT scan of his C-spine\\nshowed fracture of anterior and posterior elements at C6-7.  He\\nwas also shown to have a right nasal bone fracture.\\n\\nC-spine fracture: Mr. [**Known lastname 1829**] [**Last Name (Titles) 1834**] two surgical\\nprocedures to stabilized his c-spine.  [**2162-3-4**]: anterior\\ncervical decompression/fusion at C6-7.  [**2162-3-5**]: Cervical\\nlaminectomy C6-C7 & T1 with Posterior cervical arthrodesis\\nC4-T1.  He tolerated the procedures well.  He was extubated\\nwithout complication.\\n\\nAfter his surgical procedures, Mr. [**Known lastname 1829**] was transfered\\nto the medicine service at [**Hospital1 18**] for his medical care. While on\\nthe medicine service, patient was found to be persistently\\naspirating and failed his speech and swallow evaluation. Patient\\nand family were not interested in an NG tube or PEG for\\nnutrition. Patient also developed a venous clot of the right\\nupper extremity and the decision was made to not proceed with\\nmedical treatment. Goals of care were changed to comfort\\nmeasures only. A foley was placed after patient had difficulty\\nwith urinary retention and straight cathing. A palliative care\\nconsult was obtained for symptom management and patient was\\ndischarged to hospice with morphine, olanzapine, and a foley in\\nplace for symptomatic relief.\\n\\nMedications on Admission:\\nCoumadin\\nseroquel\\ndocusate\\nmetoprolol\\nfolate\\nlovastatin\\ncaptopril\\nASA\\nipratroium inhaler\\nFerrous sulfate\\nfurosemide\\ncitalopram\\nisosorbide\\nmeprazole\\n\\nDischarge Medications:\\n1. Bisacodyl 10 mg Suppository Sig: [**12-30**] Suppositorys Rectal\\nDAILY (Daily) as needed for constipation.\\n2. Ipratropium Bromide 0.02 % Solution Sig: One (1) nebulizer\\nInhalation Q6H (every 6 hours) as needed for wheezing.\\n3. Albuterol Sulfate 2.5 mg/3 mL Solution for Nebulization Sig:\\nOne (1) solution Inhalation Q6H (every 6 hours) as needed for\\nwheezing.\\n4. Morphine Concentrate 20 mg/mL Solution Sig: 5-10 mg PO Q4H\\n(every 4 hours) as needed for pain: may shorten interval as\\nneeded to control pain.\\n5. Olanzapine 5 mg Tablet, Rapid Dissolve Sig: 0.5 Tablet, Rapid\\nDissolve PO QHS (once a day (at bedtime)) as needed for\\nagitation.\\n6. Tamsulosin 0.4 mg Capsule, Sust. Release 24 hr Sig: One (1)\\nCapsule, Sust. Release 24 hr PO DAILY (Daily): may be\\ndiscontinued if patient not tolerating pills or refusing to\\ntake.\\n\\n\\nDischarge Disposition:\\nExtended Care\\n\\nFacility:\\n[**Hospital1 599**] of [**Location (un) 55**]\\n\\nDischarge Diagnosis:\\n1. Cervical spondylosis with calcification of posterior\\nlongitudinal ligament.\\n2. Fracture dislocation C6-C7.\\n3. Ossification of the posterior longitudinal ligament.\\n4. Aspiration Pneumonia\\n\\n\\n1. Cervical spondylosis with calcification of posterior\\n    longitudinal ligament.\\n2. Fracture dislocation C6-C7.\\n3. Ossification of the posterior longitudinal ligament.\\n4. Aspiration Pneumonia\\n\\n1. Cervical spondylosis with calcification of posterior\\n    longitudinal ligament.\\n2. Fracture dislocation C6-C7.\\n3. Ossification of the posterior longitudinal ligament.\\n4. Aspiration Pneumonia\\n\\n\\nDischarge Condition:\\nStable to outside facility\\n\\n\\nDischarge Instructions:\\nPatient has been made CMO at the request of him and his family.\\nHe has a foley placed for urinary retention. Please use morphine\\nas needed for pain and olanzapine as needed for agitiation.\\nPatient has known history of aspiration documented on speech and\\nswallow. It is the patient and the family's wish for him to\\ncontinue to eat and drink as desired.\\n\\nFollowup Instructions:\\nFollow up with your primary care physician as needed.\\n\\n\\n\\n  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "notes.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'The number of patients whose notes are stored 46146'"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\"The number of patients whose notes are stored %s\"%(len(notes['SUBJECT_ID'].unique()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 450x300 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import seaborn as sns\n",
    "\n",
    "documents_per_patient = notes.groupby(['SUBJECT_ID'])['SUBJECT_ID'].count().sort_values()\n",
    "sns.displot(documents_per_patient, kde=False, height=3, aspect=1.5);\n",
    "plt.xlabel(\"Documents per patient\");"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 400x300 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "#check the extentt of missing values\n",
    "plt.figure(figsize=(4,3))\n",
    "empt_df = notes.isnull().sum().reset_index().rename(columns={0:'count'})\n",
    "sns.barplot(data=empt_df, x='index', y='count');\n",
    "plt.xticks(rotation=90);\n",
    "plt.xlabel(\"Column\");"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>TEXT</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Admission Date:  [**2151-7-16**]       Discharge Date:  [**2151-8-4**]\\n\\n\\nService:\\nADDENDUM:\\n\\nRADIOLOGIC STUDIES:  Radiologic studies also included a chest\\nCT, which confirmed cavitary lesions in the left lung apex\\nconsistent with infectious process/tuberculosis.  This also\\nmoderate-sized left pleural effusion.\\n\\nHEAD CT:  Head CT showed no intracranial hemorrhage or mass\\neffect, but old infarction consistent with past medical\\nhistory.\\n\\nABDOMINAL CT:  Abdominal CT showed lesions of\\nT10 and sacrum most likely secondary to osteoporosis. These can\\nbe followed by repeat imaging as an outpatient.\\n\\n\\n\\n                            [**First Name8 (NamePattern2) **] [**First Name4 (NamePattern1) 1775**] [**Last Name (NamePattern1) **], M.D.  [**MD Number(1) 1776**]\\n\\nDictated By:[**Hospital 1807**]\\nMEDQUIST36\\n\\nD:  [**2151-8-5**]  12:11\\nT:  [**2151-8-5**]  12:21\\nJOB#:  [**Job Number 1808**]\\n</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Admission Date:  [**2118-6-2**]       Discharge Date:  [**2118-6-14**]\\n\\nDate of Birth:                    Sex:  F\\n\\nService:  MICU and then to [**Doctor Last Name **] Medicine\\n\\nHISTORY OF PRESENT ILLNESS:  This is an 81-year-old female\\nwith a history of emphysema (not on home O2), who presents\\nwith three days of shortness of breath thought by her primary\\ncare doctor to be a COPD flare.  Two days prior to admission,\\nshe was started on a prednisone taper and one day prior to\\nadmission she required oxygen at home in order to maintain\\noxygen saturation greater than 90%.  She has also been on\\nlevofloxacin and nebulizers, and was not getting better, and\\npresented to the [**Hospital1 18**] Emergency Room.\\n\\nIn the [**Hospital3 **] Emergency Room, her oxygen saturation was\\n100% on CPAP.  She was not able to be weaned off of this\\ndespite nebulizer treatment and Solu-Medrol 125 mg IV x2.\\n\\nReview of systems is negative for the following:  Fevers,\\nchills, nausea, vomiting, night sweats, change in weight,\\ngastrointestinal complaints, neurologic changes, rashes,\\npalpitations, orthopnea.  Is positive for the following:\\nChest pressure occasionally with shortness of breath with\\nexertion, some shortness of breath that is positionally\\nrelated, but is improved with nebulizer treatment.\\n\\nPAST MEDICAL HISTORY:\\n1. COPD.  Last pulmonary function tests in [**2117-11-3**]\\ndemonstrated a FVC of 52% of predicted, a FEV1 of 54% of\\npredicted, a MMF of 23% of predicted, and a FEV1:FVC ratio of\\n67% of predicted, that does not improve with bronchodilator\\ntreatment.  The FVC, however, does significantly improve with\\nbronchodilator treatment consistent with her known reversible\\nair flow obstruction in addition to an underlying restrictive\\nventilatory defect.  The patient has never been on home\\noxygen prior to this recent episode.  She has never been on\\nsteroid taper or been intubated in the past.\\n2. Lacunar CVA.  MRI of the head in [**2114-11-4**]\\ndemonstrates \"mild degree of multiple small foci of high T2\\nsignal within the white matter of both cerebral hemispheres\\nas well as the pons, in the latter region predominantly to\\nthe right of midline.  The abnormalities, while nonspecific\\nin etiology, are most likely secondary to chronic\\nmicrovascular infarction.  There is no mass, lesion, shift of\\nthe normal midline strictures or hydrocephalus.  The major\\nvascular flow patterns are preserved.  There is moderate\\nright maxillary, moderate bilateral ethmoid, mild left\\nmaxillary, minimal right sphenoid, and frontal sinus mucosal\\nthickening.  These abnormalities could represent an allergic\\nor some other type of inflammatory process.  Additionally\\nnoted is a moderately enlarged subtotally empty sella\\nturcica\".\\n3. Angina:  Most recent stress test was in [**2118-1-3**]\\ngoing for four minutes with a rate pressure product of\\n10,000, 64% of maximum predicted heart rate without evidence\\nof ischemic EKG changes or symptoms.  The imaging portion of\\nthe study demonstrated no evidence of myocardial ischemia and\\na calculated ejection fraction of 84%.  The patient denies\\nangina at rest and gets angina with walking a few blocks.\\nAre alleviated by sublingual nitroglycerin.\\n4. Hypothyroidism on Synthroid.\\n5. Depression on Lexapro.\\n6. Motor vehicle accident with head injury approximately 10\\nyears ago.\\n\\nMEDICATIONS ON ADMISSION:\\n1. Hydrochlorothiazide 25 q.d.\\n2. Prednisone 60 mg, 50 mg, 40 mg, 20 mg.\\n3. Levofloxacin 500 mg q.d.\\n4. Imdur 60 mg q.d.\\n5. Synthroid 75 mcg q.d.\\n6. Pulmicort nebulizer b.i.d.\\n7. Albuterol nebulizer q.4. prn.\\n8. Lexapro 10 mg q.d.\\n9. Protonix 40 mg q.d.\\n10. Aspirin 81 mg q.d.\\n\\nALLERGIES:  Norvasc leads to lightheadedness and headache.\\n\\nFAMILY HISTORY:  Noncontributory.\\n\\nSOCIAL HISTORY:  Lives with her husband, Dr. [**Known lastname 1809**] an\\neminent Pediatric Neurologist at [**Hospital3 1810**].  The\\npatient is a prior smoker, but has not smoked in over 10\\nyears.  She has no known alcohol use and she is a full code.\\n\\nPHYSICAL EXAM AT TIME OF ADMISSION:  Blood pressure 142/76,\\nheart rate 100 and regular, respirations at 17-21, and 97%\\naxillary temperature.  She was saturating at 100% on CPAP\\nwith dry mucous membranes.  An elderly female in no apparent\\ndistress.  Pupils are equal, round, and reactive to light and\\naccommodation.  Extraocular movements are intact.  Oropharynx\\ndifficult to assess due to CPAP machine.  No evidence of\\njugular venous pressure, however, the strap from the CPAP\\nmachine obscures the neck exam.  Cranial nerves II through\\nXII are grossly intact.  Neck is supple without\\nlymphadenopathy.  Heart exam:  Tachycardic, regular, obscured\\nby loud bilateral wheezing with increase in the expiratory\\nphase as well as profuse scattered rhonchi throughout the\\nlung fields.  Positive bowel sounds, soft, nontender,\\nnondistended, obese, no masses.  Mild edema of the lower\\nextremities without clubbing or cyanosis, no rashes.  There\\nis a right hand hematoma.  Strength is assessed as [**5-9**] in the\\nlower extremities, [**5-9**] in the upper extremities with a normal\\nmental status and cognition.\\n\\nLABORATORY STUDIES:  White count 19, hematocrit 41, platelets\\n300.  Chem-7:  127, 3.6, 88, 29, 17, 0.6, 143.  Troponin was\\nnegative.  CKs were negative times three.  Initial blood gas\\nshowed a pH of 7.4, pO2 of 66, pCO2 of 54.\\n\\nChest x-ray demonstrates a moderate sized hiatal hernia,\\nsegmental atelectasis, left lower lobe infiltrate versus\\nsegmental atelectasis.\\n\\nEKG shows normal sinus rhythm at 113 beats per minute, normal\\naxis, no evidence of ST-T wave changes.\\n\\nBRIEF SUMMARY OF HOSPITAL COURSE:\\n1. COPD/dyspnea/pneumonia:  The patient was initially placed\\non an aggressive steroid taper and admitted to the Medical\\nIntensive Care Unit due to her difficulty with oxygenation\\ndespite CPAP machine.  She was also given nebulizer\\ntreatments q.4h. as well as chest PT.  The nebulizers were\\nincreased to q.1h. due to the fact that she continued to have\\nlabored breathing.\\n\\nDue to persistent respiratory failure and labored breathing,\\nthe patient was intubated on [**2118-6-7**] in order to improve\\noxygenation, ventilation, and ability to suction.  A\\nbronchoscopy was performed on [**2118-6-7**], which demonstrated\\nmarked narrowing of the airways with expiration consistent\\nwith tracheomalacia.\\n\\nOn [**2118-6-9**], two silicone stents were placed, one in the left\\nmain stem (12 x 25 and one in the trachea 16 x 40) by Dr.\\n[**First Name (STitle) **] [**Name (STitle) **] under rigid bronchoscopy with general anesthesia.\\n\\nOn [**2118-6-11**], the patient was extubated to a cool mist shovel\\nmask and her oxygen was titrated down to 2 liters nasal\\ncannula at which time she was transferred to the medical\\nfloor.  On the medical floor, the steroids were weaned to off\\non [**2118-6-14**], and the patient was saturating at 97% on 2\\nliters, 92% on room air.\\n\\nOn [**2118-6-14**], the patient was seen again by the Interventional\\nPulmonology service, who agreed that she looked much improved\\nand recommended that she go to pulmonary rehabilitation with\\nfollowup within six weeks' time status post placement of\\nstents in respiratory failure.\\n\\n2. Cardiovascular:  The patient was ruled out for a MI.  She\\ndid have another episode on the medical floor of chest pain,\\nwhich showed no evidence of EKG changes and negative\\ntroponin, negative CKs x3.  She was continued on aspirin,\\nImdur, and diltiazem for rate control per her outpatient\\nregimen.\\n\\n3. Hypertension:  She was maintained on diltiazem and\\nhydrochlorothiazide with adequate blood pressure control and\\nnormalization of electrolytes.\\n\\n4. Hematuria:  The patient had intermittent hematuria likely\\nsecondary to Foley placement.  The Foley catheter was\\ndiscontinued on [**2118-6-14**].  She had serial urinalyses, which\\nwere all negative for signs of infection.\\n\\n5. Hyperglycemia:  Patient was placed on insulin-sliding\\nscale due to hyperglycemia, which was steroid induced.  This\\nworked quite well and her glucose came back to normal levels\\nonce the steroids were tapered to off.\\n\\n6. Leukocytosis:  Patient did have a profound leukocytosis of\\n20 to 22 during much of her hospital course.  As the steroids\\nwere tapered to off, her white blood cell count on [**2118-6-14**]\\nwas 15,000.  It was felt that the leukocytosis was secondary\\nto both steroids as well as question of a left lower lobe\\npneumonia.\\n\\n7. For the left lower lobe pneumonia, the patient had\\ninitially received a course of levofloxacin 500 p.o. q.d.\\nfrom [**2118-6-4**] to [**2118-6-10**].  This was restarted on [**2118-6-12**]\\nfor an additional seven day course given the fact that she\\nstill had the leukocytosis and still had marked rales at the\\nleft lower lobe.\\n\\n8. Hypothyroidism:  The patient was continued on outpatient\\nmedical regimen.\\n\\n9. Depression:  The patient was continued on Lexapro per\\noutpatient regimen.  It is recommended that she follow up\\nwith a therapist as an outpatient due to the fact that she\\ndid have a blunted affect throughout much of the hospital\\ncourse, and did appear clinically to be depressed.\\n\\n10. Prophylaxis:  She was maintained on proton-pump inhibitor\\nwith subQ Heparin.\\n\\n11. Sore throat:  The patient did have a sore throat for much\\nof the hospital course post extubation.  This was treated\\nwith Cepacol lozenges as well as KBL liquid (a solution\\ncontaining Kaopectate, Bismuth, and lidocaine) at bedtime.\\n\\n12. Communication/code status:  The patient was full code\\nthroughout her hospital course, and communication was\\nmaintained with the patient and her husband.\\n\\n13. Muscle weakness:  The patient did have profound muscle\\nweakness and was evaluated by Physical Therapy, and was found\\nto have impaired functional mobility, impaired\\nmusculoskeletal performance, impaired gas exchange, impaired\\nendurance, impaired ventilation, and needed help with supine\\nto sit.  However, she was able to tolerate sitting in a chair\\nfor approximately one hour.\\n\\nOn motor exam, her flexors and extensors of the lower\\nextremities were [**4-8**] at the knee, [**4-8**] at the ankle, [**4-8**] at\\nthe elbows, and [**4-8**] hips.  It was felt that this weakness was\\nmost likely due to a combination of steroid myopathy as well\\nas muscle atrophy secondary to deconditioning after a\\nprolonged hospital course.\\n\\n14. Speech/swallow:  The patient had a Speech and Swallow\\nevaluation showing no evidence of dysphagia, no evidence of\\nvocal cord damage status post tracheal stent placement.\\n\\nDISCHARGE CONDITION:  The patient was able to oxygenate on\\nroom air at 93% at the time of discharge.  She was profoundly\\nweak, but was no longer tachycardic and had a normal blood\\npressure.  Her respirations were much improved albeit with\\ntransmitted upper airway sounds.\\n\\nDISCHARGE STATUS:  The patient will be discharged to [**Hospital1 **]\\nfor both pulmonary and physical rehabilitation.\\n\\nDISCHARGE MEDICATIONS:\\n1. Levothyroxine 75 mcg p.o. q.d.\\n2. Citalopram 10 mg p.o. q.d.\\n3. Aspirin 81 mg p.o. q.d.\\n4. Fluticasone 110 mcg two puffs inhaled b.i.d.\\n5. Salmeterol Diskus one inhalation b.i.d.\\n6. Acetaminophen 325-650 mg p.o. q.4-6h. prn.\\n7. Ipratropium bromide MDI two puffs inhaled q.2h. prn.\\n8. Albuterol 1-2 puffs inhaled q.2h. prn.\\n9. Zolpidem tartrate 5 mg p.o. q.h.s. prn.\\n10. Isosorbide dinitrate 10 mg p.o. t.i.d.\\n11. Diltiazem 60 mg p.o. q.i.d.\\n12. Pantoprazole 40 mg p.o. q.24h.\\n13. Trazodone 25 mg p.o. q.h.s. prn.\\n14. SubQ Heparin 5000 units subcutaneous b.i.d. until such\\ntime that the patient is able to get out of bed twice a day.\\n15. Cepacol lozenges q.2h. prn.\\n16. Levofloxacin 500 mg p.o. q.d. for a seven day course to\\nbe completed on [**2118-6-21**].\\n17. Kaopectate/Benadryl/lidocaine 5 mL p.o. b.i.d. prn, not\\nto be given around mealtimes for concern of dysphagia induced\\nby lidocaine.\\n18. Lorazepam 0.5-2 mg IV q.6h. prn.\\n\\nFOLLOW-UP PLANS:  The patient is recommended to followup with\\nDr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1407**], [**Telephone/Fax (1) 1408**] within two weeks of leaving\\nof the hospital.  She is also recommended to followup with\\nthe Interventional Pulmonary service for followup status post\\nstent placement.  She is also recommended to followup with a\\nneurologist if her muscle weakness does not improve within\\none week on physical therapy with concern for steroid-induced\\nmyopathy.\\n\\nFINAL DIAGNOSES:\\n1. Tracheomalacia status post tracheal and left main stem\\nbronchial stent placement.\\n2. Hypertension.\\n3. Hypothyroidism.\\n4. Restrictive lung defect.\\n5. Depression.\\n\\n\\n                     DR.[**Last Name (STitle) **],[**First Name3 (LF) **] 12-207\\n\\n\\nDictated By:[**Last Name (NamePattern1) 1811**]\\nMEDQUIST36\\n\\nD:  [**2118-6-14**]  11:30\\nT:  [**2118-6-14**]  11:33\\nJOB#:  [**Job Number 1812**]\\n</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        TEXT\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Admission Date:  [**2151-7-16**]       Discharge Date:  [**2151-8-4**]\\n\\n\\nService:\\nADDENDUM:\\n\\nRADIOLOGIC STUDIES:  Radiologic studies also included a chest\\nCT, which confirmed cavitary lesions in the left lung apex\\nconsistent with infectious process/tuberculosis.  This also\\nmoderate-sized left pleural effusion.\\n\\nHEAD CT:  Head CT showed no intracranial hemorrhage or mass\\neffect, but old infarction consistent with past medical\\nhistory.\\n\\nABDOMINAL CT:  Abdominal CT showed lesions of\\nT10 and sacrum most likely secondary to osteoporosis. These can\\nbe followed by repeat imaging as an outpatient.\\n\\n\\n\\n                            [**First Name8 (NamePattern2) **] [**First Name4 (NamePattern1) 1775**] [**Last Name (NamePattern1) **], M.D.  [**MD Number(1) 1776**]\\n\\nDictated By:[**Hospital 1807**]\\nMEDQUIST36\\n\\nD:  [**2151-8-5**]  12:11\\nT:  [**2151-8-5**]  12:21\\nJOB#:  [**Job Number 1808**]\\n\n",
       "1  Admission Date:  [**2118-6-2**]       Discharge Date:  [**2118-6-14**]\\n\\nDate of Birth:                    Sex:  F\\n\\nService:  MICU and then to [**Doctor Last Name **] Medicine\\n\\nHISTORY OF PRESENT ILLNESS:  This is an 81-year-old female\\nwith a history of emphysema (not on home O2), who presents\\nwith three days of shortness of breath thought by her primary\\ncare doctor to be a COPD flare.  Two days prior to admission,\\nshe was started on a prednisone taper and one day prior to\\nadmission she required oxygen at home in order to maintain\\noxygen saturation greater than 90%.  She has also been on\\nlevofloxacin and nebulizers, and was not getting better, and\\npresented to the [**Hospital1 18**] Emergency Room.\\n\\nIn the [**Hospital3 **] Emergency Room, her oxygen saturation was\\n100% on CPAP.  She was not able to be weaned off of this\\ndespite nebulizer treatment and Solu-Medrol 125 mg IV x2.\\n\\nReview of systems is negative for the following:  Fevers,\\nchills, nausea, vomiting, night sweats, change in weight,\\ngastrointestinal complaints, neurologic changes, rashes,\\npalpitations, orthopnea.  Is positive for the following:\\nChest pressure occasionally with shortness of breath with\\nexertion, some shortness of breath that is positionally\\nrelated, but is improved with nebulizer treatment.\\n\\nPAST MEDICAL HISTORY:\\n1. COPD.  Last pulmonary function tests in [**2117-11-3**]\\ndemonstrated a FVC of 52% of predicted, a FEV1 of 54% of\\npredicted, a MMF of 23% of predicted, and a FEV1:FVC ratio of\\n67% of predicted, that does not improve with bronchodilator\\ntreatment.  The FVC, however, does significantly improve with\\nbronchodilator treatment consistent with her known reversible\\nair flow obstruction in addition to an underlying restrictive\\nventilatory defect.  The patient has never been on home\\noxygen prior to this recent episode.  She has never been on\\nsteroid taper or been intubated in the past.\\n2. Lacunar CVA.  MRI of the head in [**2114-11-4**]\\ndemonstrates \"mild degree of multiple small foci of high T2\\nsignal within the white matter of both cerebral hemispheres\\nas well as the pons, in the latter region predominantly to\\nthe right of midline.  The abnormalities, while nonspecific\\nin etiology, are most likely secondary to chronic\\nmicrovascular infarction.  There is no mass, lesion, shift of\\nthe normal midline strictures or hydrocephalus.  The major\\nvascular flow patterns are preserved.  There is moderate\\nright maxillary, moderate bilateral ethmoid, mild left\\nmaxillary, minimal right sphenoid, and frontal sinus mucosal\\nthickening.  These abnormalities could represent an allergic\\nor some other type of inflammatory process.  Additionally\\nnoted is a moderately enlarged subtotally empty sella\\nturcica\".\\n3. Angina:  Most recent stress test was in [**2118-1-3**]\\ngoing for four minutes with a rate pressure product of\\n10,000, 64% of maximum predicted heart rate without evidence\\nof ischemic EKG changes or symptoms.  The imaging portion of\\nthe study demonstrated no evidence of myocardial ischemia and\\na calculated ejection fraction of 84%.  The patient denies\\nangina at rest and gets angina with walking a few blocks.\\nAre alleviated by sublingual nitroglycerin.\\n4. Hypothyroidism on Synthroid.\\n5. Depression on Lexapro.\\n6. Motor vehicle accident with head injury approximately 10\\nyears ago.\\n\\nMEDICATIONS ON ADMISSION:\\n1. Hydrochlorothiazide 25 q.d.\\n2. Prednisone 60 mg, 50 mg, 40 mg, 20 mg.\\n3. Levofloxacin 500 mg q.d.\\n4. Imdur 60 mg q.d.\\n5. Synthroid 75 mcg q.d.\\n6. Pulmicort nebulizer b.i.d.\\n7. Albuterol nebulizer q.4. prn.\\n8. Lexapro 10 mg q.d.\\n9. Protonix 40 mg q.d.\\n10. Aspirin 81 mg q.d.\\n\\nALLERGIES:  Norvasc leads to lightheadedness and headache.\\n\\nFAMILY HISTORY:  Noncontributory.\\n\\nSOCIAL HISTORY:  Lives with her husband, Dr. [**Known lastname 1809**] an\\neminent Pediatric Neurologist at [**Hospital3 1810**].  The\\npatient is a prior smoker, but has not smoked in over 10\\nyears.  She has no known alcohol use and she is a full code.\\n\\nPHYSICAL EXAM AT TIME OF ADMISSION:  Blood pressure 142/76,\\nheart rate 100 and regular, respirations at 17-21, and 97%\\naxillary temperature.  She was saturating at 100% on CPAP\\nwith dry mucous membranes.  An elderly female in no apparent\\ndistress.  Pupils are equal, round, and reactive to light and\\naccommodation.  Extraocular movements are intact.  Oropharynx\\ndifficult to assess due to CPAP machine.  No evidence of\\njugular venous pressure, however, the strap from the CPAP\\nmachine obscures the neck exam.  Cranial nerves II through\\nXII are grossly intact.  Neck is supple without\\nlymphadenopathy.  Heart exam:  Tachycardic, regular, obscured\\nby loud bilateral wheezing with increase in the expiratory\\nphase as well as profuse scattered rhonchi throughout the\\nlung fields.  Positive bowel sounds, soft, nontender,\\nnondistended, obese, no masses.  Mild edema of the lower\\nextremities without clubbing or cyanosis, no rashes.  There\\nis a right hand hematoma.  Strength is assessed as [**5-9**] in the\\nlower extremities, [**5-9**] in the upper extremities with a normal\\nmental status and cognition.\\n\\nLABORATORY STUDIES:  White count 19, hematocrit 41, platelets\\n300.  Chem-7:  127, 3.6, 88, 29, 17, 0.6, 143.  Troponin was\\nnegative.  CKs were negative times three.  Initial blood gas\\nshowed a pH of 7.4, pO2 of 66, pCO2 of 54.\\n\\nChest x-ray demonstrates a moderate sized hiatal hernia,\\nsegmental atelectasis, left lower lobe infiltrate versus\\nsegmental atelectasis.\\n\\nEKG shows normal sinus rhythm at 113 beats per minute, normal\\naxis, no evidence of ST-T wave changes.\\n\\nBRIEF SUMMARY OF HOSPITAL COURSE:\\n1. COPD/dyspnea/pneumonia:  The patient was initially placed\\non an aggressive steroid taper and admitted to the Medical\\nIntensive Care Unit due to her difficulty with oxygenation\\ndespite CPAP machine.  She was also given nebulizer\\ntreatments q.4h. as well as chest PT.  The nebulizers were\\nincreased to q.1h. due to the fact that she continued to have\\nlabored breathing.\\n\\nDue to persistent respiratory failure and labored breathing,\\nthe patient was intubated on [**2118-6-7**] in order to improve\\noxygenation, ventilation, and ability to suction.  A\\nbronchoscopy was performed on [**2118-6-7**], which demonstrated\\nmarked narrowing of the airways with expiration consistent\\nwith tracheomalacia.\\n\\nOn [**2118-6-9**], two silicone stents were placed, one in the left\\nmain stem (12 x 25 and one in the trachea 16 x 40) by Dr.\\n[**First Name (STitle) **] [**Name (STitle) **] under rigid bronchoscopy with general anesthesia.\\n\\nOn [**2118-6-11**], the patient was extubated to a cool mist shovel\\nmask and her oxygen was titrated down to 2 liters nasal\\ncannula at which time she was transferred to the medical\\nfloor.  On the medical floor, the steroids were weaned to off\\non [**2118-6-14**], and the patient was saturating at 97% on 2\\nliters, 92% on room air.\\n\\nOn [**2118-6-14**], the patient was seen again by the Interventional\\nPulmonology service, who agreed that she looked much improved\\nand recommended that she go to pulmonary rehabilitation with\\nfollowup within six weeks' time status post placement of\\nstents in respiratory failure.\\n\\n2. Cardiovascular:  The patient was ruled out for a MI.  She\\ndid have another episode on the medical floor of chest pain,\\nwhich showed no evidence of EKG changes and negative\\ntroponin, negative CKs x3.  She was continued on aspirin,\\nImdur, and diltiazem for rate control per her outpatient\\nregimen.\\n\\n3. Hypertension:  She was maintained on diltiazem and\\nhydrochlorothiazide with adequate blood pressure control and\\nnormalization of electrolytes.\\n\\n4. Hematuria:  The patient had intermittent hematuria likely\\nsecondary to Foley placement.  The Foley catheter was\\ndiscontinued on [**2118-6-14**].  She had serial urinalyses, which\\nwere all negative for signs of infection.\\n\\n5. Hyperglycemia:  Patient was placed on insulin-sliding\\nscale due to hyperglycemia, which was steroid induced.  This\\nworked quite well and her glucose came back to normal levels\\nonce the steroids were tapered to off.\\n\\n6. Leukocytosis:  Patient did have a profound leukocytosis of\\n20 to 22 during much of her hospital course.  As the steroids\\nwere tapered to off, her white blood cell count on [**2118-6-14**]\\nwas 15,000.  It was felt that the leukocytosis was secondary\\nto both steroids as well as question of a left lower lobe\\npneumonia.\\n\\n7. For the left lower lobe pneumonia, the patient had\\ninitially received a course of levofloxacin 500 p.o. q.d.\\nfrom [**2118-6-4**] to [**2118-6-10**].  This was restarted on [**2118-6-12**]\\nfor an additional seven day course given the fact that she\\nstill had the leukocytosis and still had marked rales at the\\nleft lower lobe.\\n\\n8. Hypothyroidism:  The patient was continued on outpatient\\nmedical regimen.\\n\\n9. Depression:  The patient was continued on Lexapro per\\noutpatient regimen.  It is recommended that she follow up\\nwith a therapist as an outpatient due to the fact that she\\ndid have a blunted affect throughout much of the hospital\\ncourse, and did appear clinically to be depressed.\\n\\n10. Prophylaxis:  She was maintained on proton-pump inhibitor\\nwith subQ Heparin.\\n\\n11. Sore throat:  The patient did have a sore throat for much\\nof the hospital course post extubation.  This was treated\\nwith Cepacol lozenges as well as KBL liquid (a solution\\ncontaining Kaopectate, Bismuth, and lidocaine) at bedtime.\\n\\n12. Communication/code status:  The patient was full code\\nthroughout her hospital course, and communication was\\nmaintained with the patient and her husband.\\n\\n13. Muscle weakness:  The patient did have profound muscle\\nweakness and was evaluated by Physical Therapy, and was found\\nto have impaired functional mobility, impaired\\nmusculoskeletal performance, impaired gas exchange, impaired\\nendurance, impaired ventilation, and needed help with supine\\nto sit.  However, she was able to tolerate sitting in a chair\\nfor approximately one hour.\\n\\nOn motor exam, her flexors and extensors of the lower\\nextremities were [**4-8**] at the knee, [**4-8**] at the ankle, [**4-8**] at\\nthe elbows, and [**4-8**] hips.  It was felt that this weakness was\\nmost likely due to a combination of steroid myopathy as well\\nas muscle atrophy secondary to deconditioning after a\\nprolonged hospital course.\\n\\n14. Speech/swallow:  The patient had a Speech and Swallow\\nevaluation showing no evidence of dysphagia, no evidence of\\nvocal cord damage status post tracheal stent placement.\\n\\nDISCHARGE CONDITION:  The patient was able to oxygenate on\\nroom air at 93% at the time of discharge.  She was profoundly\\nweak, but was no longer tachycardic and had a normal blood\\npressure.  Her respirations were much improved albeit with\\ntransmitted upper airway sounds.\\n\\nDISCHARGE STATUS:  The patient will be discharged to [**Hospital1 **]\\nfor both pulmonary and physical rehabilitation.\\n\\nDISCHARGE MEDICATIONS:\\n1. Levothyroxine 75 mcg p.o. q.d.\\n2. Citalopram 10 mg p.o. q.d.\\n3. Aspirin 81 mg p.o. q.d.\\n4. Fluticasone 110 mcg two puffs inhaled b.i.d.\\n5. Salmeterol Diskus one inhalation b.i.d.\\n6. Acetaminophen 325-650 mg p.o. q.4-6h. prn.\\n7. Ipratropium bromide MDI two puffs inhaled q.2h. prn.\\n8. Albuterol 1-2 puffs inhaled q.2h. prn.\\n9. Zolpidem tartrate 5 mg p.o. q.h.s. prn.\\n10. Isosorbide dinitrate 10 mg p.o. t.i.d.\\n11. Diltiazem 60 mg p.o. q.i.d.\\n12. Pantoprazole 40 mg p.o. q.24h.\\n13. Trazodone 25 mg p.o. q.h.s. prn.\\n14. SubQ Heparin 5000 units subcutaneous b.i.d. until such\\ntime that the patient is able to get out of bed twice a day.\\n15. Cepacol lozenges q.2h. prn.\\n16. Levofloxacin 500 mg p.o. q.d. for a seven day course to\\nbe completed on [**2118-6-21**].\\n17. Kaopectate/Benadryl/lidocaine 5 mL p.o. b.i.d. prn, not\\nto be given around mealtimes for concern of dysphagia induced\\nby lidocaine.\\n18. Lorazepam 0.5-2 mg IV q.6h. prn.\\n\\nFOLLOW-UP PLANS:  The patient is recommended to followup with\\nDr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1407**], [**Telephone/Fax (1) 1408**] within two weeks of leaving\\nof the hospital.  She is also recommended to followup with\\nthe Interventional Pulmonary service for followup status post\\nstent placement.  She is also recommended to followup with a\\nneurologist if her muscle weakness does not improve within\\none week on physical therapy with concern for steroid-induced\\nmyopathy.\\n\\nFINAL DIAGNOSES:\\n1. Tracheomalacia status post tracheal and left main stem\\nbronchial stent placement.\\n2. Hypertension.\\n3. Hypothyroidism.\\n4. Restrictive lung defect.\\n5. Depression.\\n\\n\\n                     DR.[**Last Name (STitle) **],[**First Name3 (LF) **] 12-207\\n\\n\\nDictated By:[**Last Name (NamePattern1) 1811**]\\nMEDQUIST36\\n\\nD:  [**2118-6-14**]  11:30\\nT:  [**2118-6-14**]  11:33\\nJOB#:  [**Job Number 1812**]\\n"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#check sample of notes\n",
    "notes[['TEXT']][:2]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 400x300 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(4,3))\n",
    "category = notes['CATEGORY'].value_counts().reset_index().rename(columns={\"index\":\"CATEGORY\", \"CATEGORY\":\"Frequency\"})\n",
    "sns.barplot(category, x=\"CATEGORY\", y=\"Frequency\");\n",
    "plt.xticks(rotation=90);"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "notes['sent_len'] = notes['TEXT'].apply(lambda s: len(s.split()))\n",
    "sns.displot(notes['sent_len'], kde=False, height=4, aspect=1.5);"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "import spacy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "def clean_up(s):\n",
    "    s = re.sub(r\"[\\n]+\", \" \", s)\n",
    "    s = re.sub(r\"(\\[\\*\\*)|(\\*\\*\\])\", \"\", s)\n",
    "    s = re.sub(r\"http[s]?://(?:[a-zA-Z]|[0-9]|[$-_@.&+]|[!*\\(\\),]|(?:%[0-9a-fA-F][0-9a-fA-F]))+\", \"\", s)\n",
    "    s = re.sub(r\"\\s+\", \" \", s)\n",
    "    return s"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "notes['cleaned'] = notes['TEXT'].apply(lambda s:clean_up(s))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sent_len</th>\n",
       "      <th>cleaned</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>110</td>\n",
       "      <td>Admission Date: 2151-7-16 Discharge Date: 2151-8-4 Service: ADDENDUM: RADIOLOGIC STUDIES: Radiologic studies also included a chest CT, which confirmed cavitary lesions in the left lung apex consistent with infectious process/tuberculosis. This also moderate-sized left pleural effusion. HEAD CT: Head CT showed no intracranial hemorrhage or mass effect, but old infarction consistent with past medical history. ABDOMINAL CT: Abdominal CT showed lesions of T10 and sacrum most likely secondary to osteoporosis. These can be followed by repeat imaging as an outpatient. First Name8 (NamePattern2) First Name4 (NamePattern1) 1775 Last Name (NamePattern1) , M.D. MD Number(1) 1776 Dictated By:Hospital 1807 MEDQUIST36 D: 2151-8-5 12:11 T: 2151-8-5 12:21 JOB#: Job Number 1808</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1943</td>\n",
       "      <td>Admission Date: 2118-6-2 Discharge Date: 2118-6-14 Date of Birth: Sex: F Service: MICU and then to Doctor Last Name Medicine HISTORY OF PRESENT ILLNESS: This is an 81-year-old female with a history of emphysema (not on home O2), who presents with three days of shortness of breath thought by her primary care doctor to be a COPD flare. Two days prior to admission, she was started on a prednisone taper and one day prior to admission she required oxygen at home in order to maintain oxygen saturation greater than 90%. She has also been on levofloxacin and nebulizers, and was not getting better, and presented to the Hospital1 18 Emergency Room. In the Hospital3 Emergency Room, her oxygen saturation was 100% on CPAP. She was not able to be weaned off of this despite nebulizer treatment and Solu-Medrol 125 mg IV x2. Review of systems is negative for the following: Fevers, chills, nausea, vomiting, night sweats, change in weight, gastrointestinal complaints, neurologic changes, rashes, palpitations, orthopnea. Is positive for the following: Chest pressure occasionally with shortness of breath with exertion, some shortness of breath that is positionally related, but is improved with nebulizer treatment. PAST MEDICAL HISTORY: 1. COPD. Last pulmonary function tests in 2117-11-3 demonstrated a FVC of 52% of predicted, a FEV1 of 54% of predicted, a MMF of 23% of predicted, and a FEV1:FVC ratio of 67% of predicted, that does not improve with bronchodilator treatment. The FVC, however, does significantly improve with bronchodilator treatment consistent with her known reversible air flow obstruction in addition to an underlying restrictive ventilatory defect. The patient has never been on home oxygen prior to this recent episode. She has never been on steroid taper or been intubated in the past. 2. Lacunar CVA. MRI of the head in 2114-11-4 demonstrates \"mild degree of multiple small foci of high T2 signal within the white matter of both cerebral hemispheres as well as the pons, in the latter region predominantly to the right of midline. The abnormalities, while nonspecific in etiology, are most likely secondary to chronic microvascular infarction. There is no mass, lesion, shift of the normal midline strictures or hydrocephalus. The major vascular flow patterns are preserved. There is moderate right maxillary, moderate bilateral ethmoid, mild left maxillary, minimal right sphenoid, and frontal sinus mucosal thickening. These abnormalities could represent an allergic or some other type of inflammatory process. Additionally noted is a moderately enlarged subtotally empty sella turcica\". 3. Angina: Most recent stress test was in 2118-1-3 going for four minutes with a rate pressure product of 10,000, 64% of maximum predicted heart rate without evidence of ischemic EKG changes or symptoms. The imaging portion of the study demonstrated no evidence of myocardial ischemia and a calculated ejection fraction of 84%. The patient denies angina at rest and gets angina with walking a few blocks. Are alleviated by sublingual nitroglycerin. 4. Hypothyroidism on Synthroid. 5. Depression on Lexapro. 6. Motor vehicle accident with head injury approximately 10 years ago. MEDICATIONS ON ADMISSION: 1. Hydrochlorothiazide 25 q.d. 2. Prednisone 60 mg, 50 mg, 40 mg, 20 mg. 3. Levofloxacin 500 mg q.d. 4. Imdur 60 mg q.d. 5. Synthroid 75 mcg q.d. 6. Pulmicort nebulizer b.i.d. 7. Albuterol nebulizer q.4. prn. 8. Lexapro 10 mg q.d. 9. Protonix 40 mg q.d. 10. Aspirin 81 mg q.d. ALLERGIES: Norvasc leads to lightheadedness and headache. FAMILY HISTORY: Noncontributory. SOCIAL HISTORY: Lives with her husband, Dr. Known lastname 1809 an eminent Pediatric Neurologist at Hospital3 1810. The patient is a prior smoker, but has not smoked in over 10 years. She has no known alcohol use and she is a full code. PHYSICAL EXAM AT TIME OF ADMISSION: Blood pressure 142/76, heart rate 100 and regular, respirations at 17-21, and 97% axillary temperature. She was saturating at 100% on CPAP with dry mucous membranes. An elderly female in no apparent distress. Pupils are equal, round, and reactive to light and accommodation. Extraocular movements are intact. Oropharynx difficult to assess due to CPAP machine. No evidence of jugular venous pressure, however, the strap from the CPAP machine obscures the neck exam. Cranial nerves II through XII are grossly intact. Neck is supple without lymphadenopathy. Heart exam: Tachycardic, regular, obscured by loud bilateral wheezing with increase in the expiratory phase as well as profuse scattered rhonchi throughout the lung fields. Positive bowel sounds, soft, nontender, nondistended, obese, no masses. Mild edema of the lower extremities without clubbing or cyanosis, no rashes. There is a right hand hematoma. Strength is assessed as 5-9 in the lower extremities, 5-9 in the upper extremities with a normal mental status and cognition. LABORATORY STUDIES: White count 19, hematocrit 41, platelets 300. Chem-7: 127, 3.6, 88, 29, 17, 0.6, 143. Troponin was negative. CKs were negative times three. Initial blood gas showed a pH of 7.4, pO2 of 66, pCO2 of 54. Chest x-ray demonstrates a moderate sized hiatal hernia, segmental atelectasis, left lower lobe infiltrate versus segmental atelectasis. EKG shows normal sinus rhythm at 113 beats per minute, normal axis, no evidence of ST-T wave changes. BRIEF SUMMARY OF HOSPITAL COURSE: 1. COPD/dyspnea/pneumonia: The patient was initially placed on an aggressive steroid taper and admitted to the Medical Intensive Care Unit due to her difficulty with oxygenation despite CPAP machine. She was also given nebulizer treatments q.4h. as well as chest PT. The nebulizers were increased to q.1h. due to the fact that she continued to have labored breathing. Due to persistent respiratory failure and labored breathing, the patient was intubated on 2118-6-7 in order to improve oxygenation, ventilation, and ability to suction. A bronchoscopy was performed on 2118-6-7, which demonstrated marked narrowing of the airways with expiration consistent with tracheomalacia. On 2118-6-9, two silicone stents were placed, one in the left main stem (12 x 25 and one in the trachea 16 x 40) by Dr. First Name (STitle) Name (STitle) under rigid bronchoscopy with general anesthesia. On 2118-6-11, the patient was extubated to a cool mist shovel mask and her oxygen was titrated down to 2 liters nasal cannula at which time she was transferred to the medical floor. On the medical floor, the steroids were weaned to off on 2118-6-14, and the patient was saturating at 97% on 2 liters, 92% on room air. On 2118-6-14, the patient was seen again by the Interventional Pulmonology service, who agreed that she looked much improved and recommended that she go to pulmonary rehabilitation with followup within six weeks' time status post placement of stents in respiratory failure. 2. Cardiovascular: The patient was ruled out for a MI. She did have another episode on the medical floor of chest pain, which showed no evidence of EKG changes and negative troponin, negative CKs x3. She was continued on aspirin, Imdur, and diltiazem for rate control per her outpatient regimen. 3. Hypertension: She was maintained on diltiazem and hydrochlorothiazide with adequate blood pressure control and normalization of electrolytes. 4. Hematuria: The patient had intermittent hematuria likely secondary to Foley placement. The Foley catheter was discontinued on 2118-6-14. She had serial urinalyses, which were all negative for signs of infection. 5. Hyperglycemia: Patient was placed on insulin-sliding scale due to hyperglycemia, which was steroid induced. This worked quite well and her glucose came back to normal levels once the steroids were tapered to off. 6. Leukocytosis: Patient did have a profound leukocytosis of 20 to 22 during much of her hospital course. As the steroids were tapered to off, her white blood cell count on 2118-6-14 was 15,000. It was felt that the leukocytosis was secondary to both steroids as well as question of a left lower lobe pneumonia. 7. For the left lower lobe pneumonia, the patient had initially received a course of levofloxacin 500 p.o. q.d. from 2118-6-4 to 2118-6-10. This was restarted on 2118-6-12 for an additional seven day course given the fact that she still had the leukocytosis and still had marked rales at the left lower lobe. 8. Hypothyroidism: The patient was continued on outpatient medical regimen. 9. Depression: The patient was continued on Lexapro per outpatient regimen. It is recommended that she follow up with a therapist as an outpatient due to the fact that she did have a blunted affect throughout much of the hospital course, and did appear clinically to be depressed. 10. Prophylaxis: She was maintained on proton-pump inhibitor with subQ Heparin. 11. Sore throat: The patient did have a sore throat for much of the hospital course post extubation. This was treated with Cepacol lozenges as well as KBL liquid (a solution containing Kaopectate, Bismuth, and lidocaine) at bedtime. 12. Communication/code status: The patient was full code throughout her hospital course, and communication was maintained with the patient and her husband. 13. Muscle weakness: The patient did have profound muscle weakness and was evaluated by Physical Therapy, and was found to have impaired functional mobility, impaired musculoskeletal performance, impaired gas exchange, impaired endurance, impaired ventilation, and needed help with supine to sit. However, she was able to tolerate sitting in a chair for approximately one hour. On motor exam, her flexors and extensors of the lower extremities were 4-8 at the knee, 4-8 at the ankle, 4-8 at the elbows, and 4-8 hips. It was felt that this weakness was most likely due to a combination of steroid myopathy as well as muscle atrophy secondary to deconditioning after a prolonged hospital course. 14. Speech/swallow: The patient had a Speech and Swallow evaluation showing no evidence of dysphagia, no evidence of vocal cord damage status post tracheal stent placement. DISCHARGE CONDITION: The patient was able to oxygenate on room air at 93% at the time of discharge. She was profoundly weak, but was no longer tachycardic and had a normal blood pressure. Her respirations were much improved albeit with transmitted upper airway sounds. DISCHARGE STATUS: The patient will be discharged to Hospital1 for both pulmonary and physical rehabilitation. DISCHARGE MEDICATIONS: 1. Levothyroxine 75 mcg p.o. q.d. 2. Citalopram 10 mg p.o. q.d. 3. Aspirin 81 mg p.o. q.d. 4. Fluticasone 110 mcg two puffs inhaled b.i.d. 5. Salmeterol Diskus one inhalation b.i.d. 6. Acetaminophen 325-650 mg p.o. q.4-6h. prn. 7. Ipratropium bromide MDI two puffs inhaled q.2h. prn. 8. Albuterol 1-2 puffs inhaled q.2h. prn. 9. Zolpidem tartrate 5 mg p.o. q.h.s. prn. 10. Isosorbide dinitrate 10 mg p.o. t.i.d. 11. Diltiazem 60 mg p.o. q.i.d. 12. Pantoprazole 40 mg p.o. q.24h. 13. Trazodone 25 mg p.o. q.h.s. prn. 14. SubQ Heparin 5000 units subcutaneous b.i.d. until such time that the patient is able to get out of bed twice a day. 15. Cepacol lozenges q.2h. prn. 16. Levofloxacin 500 mg p.o. q.d. for a seven day course to be completed on 2118-6-21. 17. Kaopectate/Benadryl/lidocaine 5 mL p.o. b.i.d. prn, not to be given around mealtimes for concern of dysphagia induced by lidocaine. 18. Lorazepam 0.5-2 mg IV q.6h. prn. FOLLOW-UP PLANS: The patient is recommended to followup with Dr. First Name4 (NamePattern1) Last Name (NamePattern1) 1407, Telephone/Fax (1) 1408 within two weeks of leaving of the hospital. She is also recommended to followup with the Interventional Pulmonary service for followup status post stent placement. She is also recommended to followup with a neurologist if her muscle weakness does not improve within one week on physical therapy with concern for steroid-induced myopathy. FINAL DIAGNOSES: 1. Tracheomalacia status post tracheal and left main stem bronchial stent placement. 2. Hypertension. 3. Hypothyroidism. 4. Restrictive lung defect. 5. Depression. DR.Last Name (STitle) ,First Name3 (LF) 12-207 Dictated By:Last Name (NamePattern1) 1811 MEDQUIST36 D: 2118-6-14 11:30 T: 2118-6-14 11:33 JOB#: Job Number 1812</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   sent_len  \\\n",
       "0       110   \n",
       "1      1943   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          cleaned  \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Admission Date: 2151-7-16 Discharge Date: 2151-8-4 Service: ADDENDUM: RADIOLOGIC STUDIES: Radiologic studies also included a chest CT, which confirmed cavitary lesions in the left lung apex consistent with infectious process/tuberculosis. This also moderate-sized left pleural effusion. HEAD CT: Head CT showed no intracranial hemorrhage or mass effect, but old infarction consistent with past medical history. ABDOMINAL CT: Abdominal CT showed lesions of T10 and sacrum most likely secondary to osteoporosis. These can be followed by repeat imaging as an outpatient. First Name8 (NamePattern2) First Name4 (NamePattern1) 1775 Last Name (NamePattern1) , M.D. MD Number(1) 1776 Dictated By:Hospital 1807 MEDQUIST36 D: 2151-8-5 12:11 T: 2151-8-5 12:21 JOB#: Job Number 1808   \n",
       "1  Admission Date: 2118-6-2 Discharge Date: 2118-6-14 Date of Birth: Sex: F Service: MICU and then to Doctor Last Name Medicine HISTORY OF PRESENT ILLNESS: This is an 81-year-old female with a history of emphysema (not on home O2), who presents with three days of shortness of breath thought by her primary care doctor to be a COPD flare. Two days prior to admission, she was started on a prednisone taper and one day prior to admission she required oxygen at home in order to maintain oxygen saturation greater than 90%. She has also been on levofloxacin and nebulizers, and was not getting better, and presented to the Hospital1 18 Emergency Room. In the Hospital3 Emergency Room, her oxygen saturation was 100% on CPAP. She was not able to be weaned off of this despite nebulizer treatment and Solu-Medrol 125 mg IV x2. Review of systems is negative for the following: Fevers, chills, nausea, vomiting, night sweats, change in weight, gastrointestinal complaints, neurologic changes, rashes, palpitations, orthopnea. Is positive for the following: Chest pressure occasionally with shortness of breath with exertion, some shortness of breath that is positionally related, but is improved with nebulizer treatment. PAST MEDICAL HISTORY: 1. COPD. Last pulmonary function tests in 2117-11-3 demonstrated a FVC of 52% of predicted, a FEV1 of 54% of predicted, a MMF of 23% of predicted, and a FEV1:FVC ratio of 67% of predicted, that does not improve with bronchodilator treatment. The FVC, however, does significantly improve with bronchodilator treatment consistent with her known reversible air flow obstruction in addition to an underlying restrictive ventilatory defect. The patient has never been on home oxygen prior to this recent episode. She has never been on steroid taper or been intubated in the past. 2. Lacunar CVA. MRI of the head in 2114-11-4 demonstrates \"mild degree of multiple small foci of high T2 signal within the white matter of both cerebral hemispheres as well as the pons, in the latter region predominantly to the right of midline. The abnormalities, while nonspecific in etiology, are most likely secondary to chronic microvascular infarction. There is no mass, lesion, shift of the normal midline strictures or hydrocephalus. The major vascular flow patterns are preserved. There is moderate right maxillary, moderate bilateral ethmoid, mild left maxillary, minimal right sphenoid, and frontal sinus mucosal thickening. These abnormalities could represent an allergic or some other type of inflammatory process. Additionally noted is a moderately enlarged subtotally empty sella turcica\". 3. Angina: Most recent stress test was in 2118-1-3 going for four minutes with a rate pressure product of 10,000, 64% of maximum predicted heart rate without evidence of ischemic EKG changes or symptoms. The imaging portion of the study demonstrated no evidence of myocardial ischemia and a calculated ejection fraction of 84%. The patient denies angina at rest and gets angina with walking a few blocks. Are alleviated by sublingual nitroglycerin. 4. Hypothyroidism on Synthroid. 5. Depression on Lexapro. 6. Motor vehicle accident with head injury approximately 10 years ago. MEDICATIONS ON ADMISSION: 1. Hydrochlorothiazide 25 q.d. 2. Prednisone 60 mg, 50 mg, 40 mg, 20 mg. 3. Levofloxacin 500 mg q.d. 4. Imdur 60 mg q.d. 5. Synthroid 75 mcg q.d. 6. Pulmicort nebulizer b.i.d. 7. Albuterol nebulizer q.4. prn. 8. Lexapro 10 mg q.d. 9. Protonix 40 mg q.d. 10. Aspirin 81 mg q.d. ALLERGIES: Norvasc leads to lightheadedness and headache. FAMILY HISTORY: Noncontributory. SOCIAL HISTORY: Lives with her husband, Dr. Known lastname 1809 an eminent Pediatric Neurologist at Hospital3 1810. The patient is a prior smoker, but has not smoked in over 10 years. She has no known alcohol use and she is a full code. PHYSICAL EXAM AT TIME OF ADMISSION: Blood pressure 142/76, heart rate 100 and regular, respirations at 17-21, and 97% axillary temperature. She was saturating at 100% on CPAP with dry mucous membranes. An elderly female in no apparent distress. Pupils are equal, round, and reactive to light and accommodation. Extraocular movements are intact. Oropharynx difficult to assess due to CPAP machine. No evidence of jugular venous pressure, however, the strap from the CPAP machine obscures the neck exam. Cranial nerves II through XII are grossly intact. Neck is supple without lymphadenopathy. Heart exam: Tachycardic, regular, obscured by loud bilateral wheezing with increase in the expiratory phase as well as profuse scattered rhonchi throughout the lung fields. Positive bowel sounds, soft, nontender, nondistended, obese, no masses. Mild edema of the lower extremities without clubbing or cyanosis, no rashes. There is a right hand hematoma. Strength is assessed as 5-9 in the lower extremities, 5-9 in the upper extremities with a normal mental status and cognition. LABORATORY STUDIES: White count 19, hematocrit 41, platelets 300. Chem-7: 127, 3.6, 88, 29, 17, 0.6, 143. Troponin was negative. CKs were negative times three. Initial blood gas showed a pH of 7.4, pO2 of 66, pCO2 of 54. Chest x-ray demonstrates a moderate sized hiatal hernia, segmental atelectasis, left lower lobe infiltrate versus segmental atelectasis. EKG shows normal sinus rhythm at 113 beats per minute, normal axis, no evidence of ST-T wave changes. BRIEF SUMMARY OF HOSPITAL COURSE: 1. COPD/dyspnea/pneumonia: The patient was initially placed on an aggressive steroid taper and admitted to the Medical Intensive Care Unit due to her difficulty with oxygenation despite CPAP machine. She was also given nebulizer treatments q.4h. as well as chest PT. The nebulizers were increased to q.1h. due to the fact that she continued to have labored breathing. Due to persistent respiratory failure and labored breathing, the patient was intubated on 2118-6-7 in order to improve oxygenation, ventilation, and ability to suction. A bronchoscopy was performed on 2118-6-7, which demonstrated marked narrowing of the airways with expiration consistent with tracheomalacia. On 2118-6-9, two silicone stents were placed, one in the left main stem (12 x 25 and one in the trachea 16 x 40) by Dr. First Name (STitle) Name (STitle) under rigid bronchoscopy with general anesthesia. On 2118-6-11, the patient was extubated to a cool mist shovel mask and her oxygen was titrated down to 2 liters nasal cannula at which time she was transferred to the medical floor. On the medical floor, the steroids were weaned to off on 2118-6-14, and the patient was saturating at 97% on 2 liters, 92% on room air. On 2118-6-14, the patient was seen again by the Interventional Pulmonology service, who agreed that she looked much improved and recommended that she go to pulmonary rehabilitation with followup within six weeks' time status post placement of stents in respiratory failure. 2. Cardiovascular: The patient was ruled out for a MI. She did have another episode on the medical floor of chest pain, which showed no evidence of EKG changes and negative troponin, negative CKs x3. She was continued on aspirin, Imdur, and diltiazem for rate control per her outpatient regimen. 3. Hypertension: She was maintained on diltiazem and hydrochlorothiazide with adequate blood pressure control and normalization of electrolytes. 4. Hematuria: The patient had intermittent hematuria likely secondary to Foley placement. The Foley catheter was discontinued on 2118-6-14. She had serial urinalyses, which were all negative for signs of infection. 5. Hyperglycemia: Patient was placed on insulin-sliding scale due to hyperglycemia, which was steroid induced. This worked quite well and her glucose came back to normal levels once the steroids were tapered to off. 6. Leukocytosis: Patient did have a profound leukocytosis of 20 to 22 during much of her hospital course. As the steroids were tapered to off, her white blood cell count on 2118-6-14 was 15,000. It was felt that the leukocytosis was secondary to both steroids as well as question of a left lower lobe pneumonia. 7. For the left lower lobe pneumonia, the patient had initially received a course of levofloxacin 500 p.o. q.d. from 2118-6-4 to 2118-6-10. This was restarted on 2118-6-12 for an additional seven day course given the fact that she still had the leukocytosis and still had marked rales at the left lower lobe. 8. Hypothyroidism: The patient was continued on outpatient medical regimen. 9. Depression: The patient was continued on Lexapro per outpatient regimen. It is recommended that she follow up with a therapist as an outpatient due to the fact that she did have a blunted affect throughout much of the hospital course, and did appear clinically to be depressed. 10. Prophylaxis: She was maintained on proton-pump inhibitor with subQ Heparin. 11. Sore throat: The patient did have a sore throat for much of the hospital course post extubation. This was treated with Cepacol lozenges as well as KBL liquid (a solution containing Kaopectate, Bismuth, and lidocaine) at bedtime. 12. Communication/code status: The patient was full code throughout her hospital course, and communication was maintained with the patient and her husband. 13. Muscle weakness: The patient did have profound muscle weakness and was evaluated by Physical Therapy, and was found to have impaired functional mobility, impaired musculoskeletal performance, impaired gas exchange, impaired endurance, impaired ventilation, and needed help with supine to sit. However, she was able to tolerate sitting in a chair for approximately one hour. On motor exam, her flexors and extensors of the lower extremities were 4-8 at the knee, 4-8 at the ankle, 4-8 at the elbows, and 4-8 hips. It was felt that this weakness was most likely due to a combination of steroid myopathy as well as muscle atrophy secondary to deconditioning after a prolonged hospital course. 14. Speech/swallow: The patient had a Speech and Swallow evaluation showing no evidence of dysphagia, no evidence of vocal cord damage status post tracheal stent placement. DISCHARGE CONDITION: The patient was able to oxygenate on room air at 93% at the time of discharge. She was profoundly weak, but was no longer tachycardic and had a normal blood pressure. Her respirations were much improved albeit with transmitted upper airway sounds. DISCHARGE STATUS: The patient will be discharged to Hospital1 for both pulmonary and physical rehabilitation. DISCHARGE MEDICATIONS: 1. Levothyroxine 75 mcg p.o. q.d. 2. Citalopram 10 mg p.o. q.d. 3. Aspirin 81 mg p.o. q.d. 4. Fluticasone 110 mcg two puffs inhaled b.i.d. 5. Salmeterol Diskus one inhalation b.i.d. 6. Acetaminophen 325-650 mg p.o. q.4-6h. prn. 7. Ipratropium bromide MDI two puffs inhaled q.2h. prn. 8. Albuterol 1-2 puffs inhaled q.2h. prn. 9. Zolpidem tartrate 5 mg p.o. q.h.s. prn. 10. Isosorbide dinitrate 10 mg p.o. t.i.d. 11. Diltiazem 60 mg p.o. q.i.d. 12. Pantoprazole 40 mg p.o. q.24h. 13. Trazodone 25 mg p.o. q.h.s. prn. 14. SubQ Heparin 5000 units subcutaneous b.i.d. until such time that the patient is able to get out of bed twice a day. 15. Cepacol lozenges q.2h. prn. 16. Levofloxacin 500 mg p.o. q.d. for a seven day course to be completed on 2118-6-21. 17. Kaopectate/Benadryl/lidocaine 5 mL p.o. b.i.d. prn, not to be given around mealtimes for concern of dysphagia induced by lidocaine. 18. Lorazepam 0.5-2 mg IV q.6h. prn. FOLLOW-UP PLANS: The patient is recommended to followup with Dr. First Name4 (NamePattern1) Last Name (NamePattern1) 1407, Telephone/Fax (1) 1408 within two weeks of leaving of the hospital. She is also recommended to followup with the Interventional Pulmonary service for followup status post stent placement. She is also recommended to followup with a neurologist if her muscle weakness does not improve within one week on physical therapy with concern for steroid-induced myopathy. FINAL DIAGNOSES: 1. Tracheomalacia status post tracheal and left main stem bronchial stent placement. 2. Hypertension. 3. Hypothyroidism. 4. Restrictive lung defect. 5. Depression. DR.Last Name (STitle) ,First Name3 (LF) 12-207 Dictated By:Last Name (NamePattern1) 1811 MEDQUIST36 D: 2118-6-14 11:30 T: 2118-6-14 11:33 JOB#: Job Number 1812   "
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "notes.iloc[:2,-2:]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import seaborn as sns\n",
    "import json \n",
    "\n",
    "from matplotlib import pyplot as plt\n",
    "from medcat.cat import CAT\n",
    "from medcat.cdb import CDB\n",
    "from medcat.config import Config\n",
    "from medcat.vocab import Vocab\n",
    "from medcat.meta_cat import MetaCAT\n",
    "from medcat.preprocessing.tokenizers import TokenizerWrapperBPE\n",
    "from tokenizers import ByteLevelBPETokenizer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "# format the df to match: required input data for multiprocessing = [(doc_id, doc_text), (doc_id, doc_text), ...]\n",
    "def data_iterator(data):\n",
    "    for id, row in data[['cleaned']].iterrows():\n",
    "        yield (id, str(row['cleaned']))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/micheala/v_environs/lib/python3.10/site-packages/spacy/util.py:887: UserWarning: [W095] Model 'en_core_web_md' (3.1.0) was trained with spaCy v3.1 and may not be 100% compatible with the current version (3.5.3). If you see errors or degraded performance, download a newer compatible model or retrain your custom model with the current spaCy version. For more details and available updates, run: python -m spacy validate\n",
      "  warnings.warn(warn_msg)\n"
     ]
    }
   ],
   "source": [
    "# Load model pack and Create CAT - the main class from medcat used for concept annotation\n",
    "# Create the full pipeline with models for meta-annotations\n",
    "model_pack_path = 'models/medmen_wstatus_2021_oct.zip'\n",
    "cat = CAT.load_model_pack(model_pack_path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "mc_modelpack_snomed_int_16_mar_2022_25be3857ba34bdd5\r\n",
      "mc_modelpack_snomed_int_16_mar_2022_25be3857ba34bdd5.zip\r\n",
      "medmen_wstatus_2021_oct\r\n",
      "medmen_wstatus_2021_oct.zip\r\n",
      "umls_self_train_model_e6a3660d3ba19f52.zip\r\n"
     ]
    }
   ],
   "source": [
    "!ls models/"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 1
}
